WO2007149672A2 - Rebaudioside a composition and method for purifying rebaudioside a - Google Patents

Rebaudioside a composition and method for purifying rebaudioside a Download PDF

Info

Publication number
WO2007149672A2
WO2007149672A2 PCT/US2007/069548 US2007069548W WO2007149672A2 WO 2007149672 A2 WO2007149672 A2 WO 2007149672A2 US 2007069548 W US2007069548 W US 2007069548W WO 2007149672 A2 WO2007149672 A2 WO 2007149672A2
Authority
WO
WIPO (PCT)
Prior art keywords
rebaudioside
solution
substantially pure
composition
ethanol
Prior art date
Application number
PCT/US2007/069548
Other languages
French (fr)
Other versions
WO2007149672A3 (en
Inventor
Indra Prakash
Grant E. Dubois
George A. King
Mani Upreti
Original Assignee
The Coca-Cola Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38834209&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2007149672(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by The Coca-Cola Company filed Critical The Coca-Cola Company
Priority to AP2008004716A priority Critical patent/AP2008004716A0/en
Priority to JP2009516618A priority patent/JP5536449B2/en
Priority to CA2655440A priority patent/CA2655440C/en
Priority to MX2008016334A priority patent/MX2008016334A/en
Priority to EP07797688.4A priority patent/EP2037761B1/en
Priority to KR1020097000860A priority patent/KR101494374B1/en
Priority to AU2007261243A priority patent/AU2007261243B2/en
Priority to CN2007800226896A priority patent/CN101472487B/en
Publication of WO2007149672A2 publication Critical patent/WO2007149672A2/en
Publication of WO2007149672A3 publication Critical patent/WO2007149672A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • C07H1/06Separation; Purification
    • C07H1/08Separation; Purification from natural products
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30Artificial sweetening agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Definitions

  • REBAUDIOSIDE A COMPOSITION AND METHOD FOR PURIFYING REBAUDIOSIDE A
  • This invention relates generally to polymorphic and amorphous forms of rebaudioside A, methods for purifying rebaudioside A, and methods for preparing polymorphic and amorphous forms of rebaudioside A. More particularly, this invention relates to polymorphic and amorphous forms of rebaudioside A and methods for the purification or crystallization of rebaudioside A with aqueous organic solvents or organic solvents to obtain a product in high yield and high purity.
  • Rebaudioside A is a high-potency diterpenoid glycoside sweetener having the chemical structure:
  • Rebaudioside A is isolated and extracted, along with other steviol glycosides, from the Stevia rebaudiana (Bertoni) plant ("Stevia"), which is commercially cultivated in Japan, Singapore, Taiwan, Malaysia, South Korea, China, Israel, India, Brazil, Australia, and Paraguay. It is an alternative non-caloric sweetener with functional and sensory properties superior to those of many high-potency sweeteners. Processed forms of Stevia can be 70 to 400 times more potent than sugar; however, Slevia also has a bitter component. Of the four major diterpenoid glycoside sweeteners present in Stevia, rebaudioside A has been identified as the least bitter, and with the least persistent aftertaste. Bitterness often is significantly due to the impurities in extracts.
  • Rebaudioside A is generally available at ⁇ 80 % pure.
  • the primary impurities comprise stevioside, steviolbioside, rebaudioside B, rebaudioside C, rebaudioside D, dulcoside A, rebaudioside F, and other steviol glycosides. It is very difficult to obtain a high purity of rebaudioside A in high recovery because the rebaudioside A and the impurities have similar solubilities.
  • U.S. Patent No. 5,962,678 discloses the re-crystallization of rebaudioside A using an anhydrous methanol solution to obtain an 80 % pure rebaudioside A. By repeating the re-crystal iization with anhydrous methanol numerous times, the purity of rebaudioside A may be increased to over 95 %.
  • U.S. Patent Publication No. 2006/0083838 discloses purification of rebaudioside A through re-crystallization with a solvent comprising ethanol and between 4 and 15 % water. Japanese Patent Application No.
  • Exemplary embodiments of the invention address the above- identified need by providing a substantially pure rebaudioside A, polymorphic and amorphous forms of rebaudioside A, methods for purifying rebaudioside A, and methods for making polymorphic and amorphous forms of rebaudioside A.
  • the method for purifying rebaudioside A comprises a simple crystallization.
  • a method for purifying rebaudioside A comprises combining crude rebaudioside A and an aqueous organic solvent to form a rebaudioside A solution, the aqueous organic solution comprising water in an amount from about 10 % to about 25 % by weight, and crystallizing from the crude rebaudioside A solution, in a single step, a substantially pure rebaudioside A in a purity greater than about 95% by weight on a dry basis.
  • different polymorphic and amorphous forms of rebaudioside A and methods for preparing different polymorphic and amorphous forms of rebaudioside A are provided.
  • Fig. 1 is a schematic illustrating a method for purifying rebaudioside A in accordance with an embodiment of this invention.
  • Fig. 2 is a schematic of the formation and conversion of rebaudioside A polymorphic and amorphous forms of rebaudioside A in accordance with an embodiment of this invention.
  • Fig. 3 is a powder x-ray diffraction scan comparing four rebaudioside A polymorphs, Forms 1, 2, 3A and 3B, on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 4 is a powder x-ray diffraction scan comparing rebaudioside A polymorphs, Form 1 and Form 2, on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 5 is a powder x-ray diffraction scan comparing rebaudioside A polymorphs, Form 3 A and Form 3B, on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 6 is a powder x-ray diffraction scan comparing rebaudioside A polymorphs, Forms 2, 3 A and 3B, on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention
  • Fig. 7 is a powder x-ray diffraction scan of rebaudioside A polymorph Form I on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 8 is a powder x-ray diffraction scan of rebaudioside A polymorph Form 2 on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 9 is a powder x-ray diffraction scan of rebaudioside A polymorph Form 3A on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 10 is a powder x-ray diffraction scan of rebaudioside A polymorph Form 3B on a plot of the scattering intensity versus the scattering angle 2 ⁇ in accordance with an embodiment of this invention.
  • Fig. 1 1 is a powder x-ray diffraction scan of rebaudioside A amorphous Form 4 on a plot of the scattering intensity versus the scattering angle 20 in accordance with an embodiment of this invention.
  • Rebaudioside A is a natural high-potency sweetener that generally is available at moderate cost at ⁇ 80% purity and at > 80 % purity only at high cost. Commercial samples of rebaudioside A often have a bitter taste that is believed to be due to impurities. Accordingly, there exists a need for a substantially pure rebaudioside A and a simple and economic method for purifying rebaudioside A in order to obtain a substantially pure rebaudioside A suitable for use as a natural high-potency sweetener.
  • the term "substantially” or “substantially pure” refers to a rebaudioside A composition that includes at least about 85 % by dry weight of the rebaudioside A, in another embodiment at least about 90 % by dry weight, in another embodiment from about 95 % to about 98 % by dry weight, and in yet another embodiment from about 99 % to about 100 % by dry weight.
  • Exemplary embodiments of this invention satisfy these needs by providing a method for purifying crude rebaudioside A to substantially pure rebaudioside A by crystallizing a crude rebaudioside A from an aqueous organic solution comprising water in an amount from about 10 % to about 25 % by weight and crystallizing in at least one step a substantially pure rebaudioside A.
  • Other exemplary embodiments of this invention encompass a composition of a substantially pure rebaudioside A and compositions comprising one, or more than one, polymorph(s) of rebaudioside A.
  • Still other exemplary embodiments of this invention encompass an amorphous form of rebaudioside A and methods of preparing amorphous forms of rebaudioside A.
  • a method for converting one form of polymorph into another form of polymorph or amorphous form is provided. Exemplary embodiments of this invention are described in detail below and illustrated in Figures 1-11. Method of Purifying Crude Rebaudioside A Mixture
  • Crude rebaudioside A products are commercially available comprising rebaudioside A in purities from about 40 % to about 95 % by weight, about 60 % to about 85 % by weight, or about 70 % to about 85 % by weight. It is envisioned that crude rebaudioside A in its raw form as extracted from Stevia plants, may be purified by recrystallization.
  • the primary impurities, identified by HPLC, are stevioside, rebaudioside B, rebaudioside C, and rebaudioside D.
  • Rebaudioside D impurities can be removed by increasing the amount of water in an aqueous organic recrystallization solvent; however, excessive water content in the crystallization solvent will result in a lower recovery of rebaudioside A.
  • Rebaudioside B impurity can be reduced significantly by slurrying the crude rebaudioside A in an organic solvent or an aqueous organic solution or through treatment of the crude rebaudioside A solution with an anion exchange resin. Accordingly, the method of purification depends on the impurities present in the crude rebaudioside A starting material.
  • crude rebaudioside A 112 may be combined 114 with an aqueous organic solution 116 to form a rebaudioside A solution 118.
  • the aqueous organic solution 116 comprises water in an amount from about 10 % to about 25 % by weight and at least one organic solvent.
  • the aqueous organic solution 116 may comprise water in an amount from about 15 % to about 20 % by weight and at least one organic solvent.
  • Aqueous organic solvents refer to mixtures of water and at ieast one organic solvent. Non-limiting examples of organic solvents include alcohol, acetone, and acetonitrile.
  • Alcohol refers to any straight, branched, or cyclic; substituted or unsubstituted alkyl, alkenyl, or alkynyl group attached to at least one hydroxyl moiety.
  • Non-limiting examples of alcohols include ethanol, methanol, isopropanol, 1-propanol, 1-butanol, 2-butanol, tert-butanol, and isobutanol.
  • the aqueous organic solution 116 comprises a mixture of water and at least one organic solvent.
  • at least one organic solvent comprises an alcohol, the alcohol comprising ethanol, methanol, or mixtures thereof.
  • the ethanol and methanol may be combined in the aqueous organic solvent in a weight ratio ranging from about 20 parts to about 1 part ethanol to about 1 part methanol.
  • the ethanol and methanol may be combined in the aqueous organic solvent in a weight ratio ranging from about 3 parts to about 1 part ethanol to about 1 part methanol.
  • the rebaudioside A solution 1 18 comprises the aqueous organic solvent 116 and the crude rebaudioside A 112 in a weight ratio ranging from about 10 to about 4 parts aqueous organic solvent to about 1 part crude rebaudioside A.
  • the rebaudioside A solution 118 comprises the aqueous organic solution 116 and the crude rebaudioside A 112 in a weight ratio ranging from about 5 to about 3 parts aqueous organic solvent to about 1 part crude rebaudioside A.
  • the method 1 10 may be carried out at approximately room temperature.
  • the method 110 further comprises the step of heating 120 the rebaudioside A solution 118.
  • the step of heating 120 the rebaudioside A solution 118 comprises heating the rebaudioside A solution to a temperature in a range from about 20°C to about 70°C, from about 20°C to about 6O 0 C, from about 20°C to about 40°C, or from about 40°C to about 60°C.
  • the step of heating 120 the rebaudioside A solution 1 18 comprises heating the rebaudioside A solution to about reflux temperature.
  • the step of heating 120 the rebaudioside A solution 118 comprises heating the rebaudioside A solution for about 0.25 hours to about 8 hours.
  • the method for purifying rebaudioside A I lO comprises the step of heating 120 the rebaudioside A solution 118
  • the method further comprises the step of cooling 122 the rebaudioside A solution.
  • the step of cooling 122 the rebaudioside A solution 118 comprises cooling the rebaudioside A solution to a temperature in the range from about 4°C to about 25°C.
  • the step of cooling 122 the rebaudioside A solution 1 18 comprises cooling the rebaudioside A solution for about 0.5 hours to about 24 hours.
  • the method for purifying rebaudioside A 1 10 further comprises the step of crystallizing 124 from the rebaudioside A solution 118 in a single step a substantially pure rebaudioside A composition 126 comprising rebaudioside A in an amount greater than about 85 % by weight on a dry basis, greater than about 90 % by weight on a dry basis, greater than about 95 % by weight on a dry basis, greater than about 97 % by weight on a dry basis, greater than about 98 % by weight on a dry basis, or greater than about 99 % by weight on a dry basis.
  • the rebaudioside A solution 118 during the single crystal ⁇ zation step may be stirred or unstirred.
  • the method 110 may further comprise the optional step of seeding 128 the rebaudioside A solution 1 18 at an appropriate temperature with substantially pure crystals of rebaudioside A 130 sufficient to promote crystallization of the rebaudioside A to form pure rebaudioside A.
  • An amount of rebaudioside A 130 sufficient to promote crystallization of substantially pure rebaudioside A 126 comprises an amount of rebaudioside A from about 0.0001 % to about 1 % by weight of the rebaudioside A present in the solution.
  • an amount of rebaudioside A 130 sufficient to promote crystallization of the rebaudioside A to form a composition of a substantially pure rebaudioside A 126 comprises an amount of rebaudioside A from about 0.01 % to about 1 % by weight.
  • An appropriate temperature for the step of seeding 128 comprises a temperature in a range from about 18"C to about 35 0 C.
  • the method further comprises the steps of separating 132 and washing 134 the substantially pure rebaudioside A composition 126.
  • the substantially pure rebaudioside A composition 126 may be separated from the aqueous organic solution 118 by a variety of solid-liquid separation techniques that utilize centrifugal force, that include, without limitation, vertical and horizontal perforated basket centrifuge, solid bowl centrifuge, decanter centrifuge, peeler type centrifuge, pusher type centrifuge, Heinkel type centrifuge, disc stack centrifuge and cyclone separation.
  • separation may be enhanced by any pressure, vacuum, or gravity filtration methods, that include without limitation, the use of belt, drum, nutsche type, leaf, plate, Rosenmund type, sparkler type, and bag filters and filter press.
  • Operation of the rebaudioside A solid-liquid separation device may be continuous, semi -continuous or in batch mode.
  • the substantially pure rebaudioside A composition 126 also may be washed 134 on the separation device using various aqueous organic solvents 136 and mixtures thereof.
  • the substantially pure rebaudioside A composition 126 can be partially or totally dried on the separation device using any number of gases, including, without limitation, nitrogen or argon, to evaporate residual liquid solvent 136.
  • the substantially pure rebaudioside A composition 126 may be automatically or manually removed from the separation device using liquids, gases or mechanical means by either dissolving the solid or maintaining the solid form.
  • the method 110 further comprises the step of drying 138 the substantially pure rebaudioside A composition 126.
  • drying 138 the substantially pure rebaudioside A composition 126 Such methods are known to those skilled in the art and include, but are not limited to, the use of a rotary vacuum dryer, fluid bed dryer, rotary tunnel dryer, plate dryer, tray dryer,
  • the step of drying 138 comprises drying the substantially pure rebaudioside A composition 126 using a nitrogen or argon purge to remove the residual solvent 120 at a temperature in a range from about 4O 0 C to about 60°C for about 5 hours to about 100 hours.
  • the method 110 further comprises the step of slurrying 140 the composition of substantially pure rebaudioside A 126 with an organic solvent or an aqueous organic solvent 142 prior to the step of drying 138 the substantially pure rebaudioside A composition.
  • the slurry may be a mixture comprising a solid and an aqueous organic solvent or organic solvent, wherein the solid comprises the substantially pure rebaudioside A composition 126 and is only sparingly soluble in the aqueous organic solvent or organic solvent 142.
  • the substantially pure rebaudioside A composition 126 and aqueous organic solvent or organic solvent 142 may be present in the slurry in a weight ratio ranging from about 15 parts to about 1 part aqueous organic solvent to about 1 part substantially pure rebaudioside A composition.
  • the slurry may be maintained at room temperature.
  • the step of slurrying 140 comprises heating the slurry to a temperature in a range from about 20°C to about 40°C.
  • the substantially pure rebaudioside A composition 126 may be slurried for about 0.5 hours to about 24 hours.
  • the method further comprises the steps of separating 132 the substantially pure rebaudioside A composition 126 from the aqueous organic solvent 142 of the slurry and washing 134 the substantially pure rebaudioside A composition followed by the step of drying 138 the substantially pure rebaudioside A composition.
  • a rebaudioside A composition comprises reba ⁇ dioside A in a particular purity, with the remainder of the composition comprising a mixture of other steviol glycosides or any component that is not rebaudioside A.
  • the purity of the composition may be measured using methods known to those of ordinary skill in the art. One such method includes high performance liquid chromatography (HPLC).
  • composition should be substantially dry when measured for purity.
  • a substantially dry composition comprises up to about 10 % by weight of moisture.
  • rebaudioside A The purification of rebaudioside A using the method described hereinabove results in the formation of at least three different polymorphs of rebaudioside A: Form 1 : a rebaudioside A hydrate; Form 2: an anhydrous rebaudioside A, and Form 3: a rebaudioside A solvate.
  • Form 1 a rebaudioside A hydrate
  • Form 2 an anhydrous rebaudioside A
  • Form 3 a rebaudioside A solvate.
  • Polymorphism is defined as the ability of a substance to exist as two or more crystalline states that have different arrangements and/or conformations of the molecules in the crystal lattice. Approximately 30 % of organic compounds are believed to exhibit polymorphism (ZeIl, et al, Tetrahedron 56(36)6603-16 (2000)). Polymorphism is important in the formulation of pharmaceuticals, pigments and dyes, sweeteners, explosives, and agrochemicals. Polymorphism may cause physical properties such as density, melting point, and rate of dissolution to change. The polymorphs of rebaudioside A were identified by analysis of samples with powder x-ray diffraction (XRPD), a technique well known to those skilled in the art. Figs.
  • XRPD powder x-ray diffraction
  • 3-11 are XRPD scans of substantially pure rebaudioside A compositions obtained from the purification process described herein.
  • the XRPD scans of rebaudioside A polymorphs were created by plotting the scattering intensity versus the scattering angle 2 ⁇ .
  • Samples were analyzed by XRPD using a Shimadzu XRD-6000 X-ray powder diffractometer using Cu Ka radiation. The instrument was equipped with a long fine focus X-ray tube. The tube voltage and amperage were set to 40 kV and 40 mA, respectively.
  • the divergence and scattering slits were set at 1°, and the receiving slit was set at 0.15 mm. Diffracted radiation was detected by a NaI scintillation detector.
  • a ⁇ -2 ⁇ continuous scan at 37min (0.4 sec/0.02 o step) from 2.5 to 40° 20 was used.
  • a silicon standard was analyzed to check the instrument alignment. Data were collected and analyzed using XRD-60000 v. 4.1. The patterns exhibit resolution of reflections, indicating that the samples are comprised of crystalline material.
  • Fig. 3 shows representative patterns for Form 1, Form 2, and Forms 3 A (methanol solvate) and 3B (ethanol solvate).
  • the pattern for Form 2 (top pattern) is distinctively different from the other patterns. It should be noted that multiple polymorphs can exist within each classification of Forms 1, 2, and 3.
  • Fig. 4 highlights the differences between Forms 1 and 2. Additionally, the two patterns of Form 2 are shown to illustrate the reproducibility in generation of the different polymorphs under varying recrystallization conditions of the polymorphs.
  • Fig. 5 shows a significant similarity between the XRPD patterns of Forms 3 A and 3B. Not wishing to be bound by any theory, it is possible that these polymorphs are isostructural solvates, wherein the only differences between the patterns are the shifting of certain peaks due to the variation of the solvent identity. This isostructural relationship between Forms 3A and 3B could be verified by indexing the patterns if necessary.
  • the asterisks identify the peaks that are shifted to the right by about 0.2 degrees 2 ⁇ in the pattern for Form 3A, In addition, several peaks in Form 3B are more intense than the corresponding peaks in Form 3A. For example, the peaks at 5,5, 11.0, 14.2. and 19.4 degrees are more intense for Form 3B than for Form 3 A.
  • Fig. 6 compares Form 2 to Forms 3 A and 3B from Fig. 5.
  • Form 2 is more similar to Form 3 A than to that of Form 3B.
  • the peaks identified in Fig. 5 as being more intense in Form 3 B than in Form 3 A are not observed in the pattern of
  • Form 2 there are at least three peaks (marked with a double-asterisks underneath the patterns) that show the reverse trend (i.e., the peaks are present in Form 2, small in
  • Figs. 7-10 are XRPD scans of the individual polymorphs Form 1, Form 2, Form 3A, and Form 3B 5 respectively, from a substantially pure rebaudioside A composition obtained from the purification process described hereinabove.
  • the type of polymorph formed may be dependent on the factors such as the composition of the aqueous organic solution, the temperature of the crystallization step, and the temperature during the drying step.
  • Form 1 and Form 3 are believed to be formed during the single crystallization step while Form 2 is believed to be formed during the drying step after conversion from Form 1 and Form 3.
  • Form 1 can be converted to Form 3 by slurrying in an anhydrous solvent at about room temperature for about 2 to about 16 hours or by slurrying in an anhydrous solvent at about reflux temperature for about 0,5 to about 3 hours.
  • Form 3 can be converted to Form 1 by slurrying the polymorph in water at about room temperature for approximately 16 hours or at about reflux temperature for about 2 to about 3 hours.
  • Form 3 can be converted to the Form 2 during the drying process; however, increasing either the drying temperature above about 70°C or the drying time of a substantially pure rebaudioside A composition can result in decomposition of the rebaudioside A and increase the remaining rebaudioside B impurity in the substantially pure rebaudioside A composition.
  • Form 2 can be converted to Form 1 with the addition of water.
  • the purification of rebaudioside A may result in the formation of an amorphous form of rebaudioside A, Form 4, as shown in Fig. 1 1.
  • Form 4 has a broad amorphous halo that identifies the composition as being amorphous.
  • Amorphous describes a non-crystalline solid material.
  • the amorphous form of rebaudioside A (Form 4) has an improved rate of dissolution as compared to the polymorphic forms of rebaudioside A (Forms 1, 2, or 3).
  • the rate of dissolution of a sweetener composition may be important in the formulation of solid and liquid sweetenable compositions, non-Hrniting examples of which include chewing gum, baked goods, and beverages.
  • Form 4 may be obtained during the initial purification of rebaudioside A or directly from any individual polymorph or combination of polymorphs using methods well known to those of ordinary skill in the art.
  • Form 4 may be obtained from a crude rebaudioside A composition or a substantially pure rebaudioside A composition obtained through purification means other than those described hereinabove.
  • methods for preparing amorphous forms of rebaudioside A include ball milling, precipitation, iyophilization, cryogrinding, and spray-drying of a rebaudioside A composition.
  • the purification of rebaudioside A described hereinabove results in a composition comprising the amorphous rebaudioside A of Form 4.
  • a composition comprising the amorphous rebaudioside A of Form 4.
  • the parameters of the crystallization procedure may be modified to enhance the formation of Form 4.
  • Form 4 can be prepared from a rebaudioside
  • a composition by spray-drying a solution of the rebaudioside A composition generally requires the feed of a solution of rebaudioside A through a feed pump into a nozzle atomizer which atomizes the solution into a spray of droplets with the help of a constant flow of nitrogen/air.
  • the moisture is evaporated from the droplets under controlled temperature conditions and airflow conditions in the drying chamber, resulting in the formation of dry particles of amorphous rebaudioside A.
  • the purity of the amorphous rebaudioside A will depend upon the purity of the solution of rebaudioside A .
  • Form 4 can be prepared from a rebaudioside A composition by milling non-amorphous forms of rebaudioside A.
  • Milling is a mechanical process that is believed to produce localized areas of energy that convert crystalline forms of rebaudioside A to the amorphous form.
  • Exemplary milling techniques include ba ⁇ t milling or air jet milling, both techniques well known to those of ordinary skill in the art. Briefly described, non-amorphous forms of rebaudioside A are milled for a period of time and at a speed effective to form an amorphous rebaudioside A. These parameters may be determined by those of ordinary skill in the art. Typical milling time periods may range from about 15 minutes to about 2 hours, although other time periods also may be employed.
  • rebaudioside A composition may be modified to obtain a desired mixture of rebaudioside A polymorphic and amorphous forms depending on the desired qualities of the rebaudioside A composition (i.e., rate of dissolution, etc.).
  • a substantially pure rebaudioside A composition may comprise a particular polymorphic or amorphous form of rebaudioside A in an amount in the range of about 1 % to about 100 % by weight.
  • a substantially pure rebaudioside A composition may comprise a polymorphic or amorphous form of rebaudioside A in an amount greater than about 25 % by weight, more particularly in an amount greater than about 50 % by weight, still more particularly in an amount greater than about 75 % by weight, or still even more particularly in an amount greater than about 85 % by weight. Suitable amounts of rebaudioside A polymorphic or amorphous forms also may be used within these ranges.
  • a substantially pure rebaudioside A composition may comprise a combination of particular polymorphic and/or amorphous form of rebaudioside A.
  • the purity of the rebaudioside A compositions described in the examples hereinbelow was determined using HPLC. Methods of performing HPLC analysis are well known to those of ordinary skill in the art. Briefly described, the HPLC analysis was performed using a ZORBAX NH 2 column (150 x 4.6 mm, 5 ⁇ m) at a temperature of 30 0 C.
  • the mobile phase comprised a solution of 20 % buffer (0.0125 % acetic acid and 0.0125 % ammonium acetate) and 80 % acetonitrile at a flow rate of 1.5 mL/min, 12 ⁇ L of each sample was injected in duplicate and the sample was analyzed using a UV detector at 210 nm (4 nm bandwidth) with a reference of 260 nm (100 ran bandwidth).
  • the HPLC analysis required a run time ranging from 40 to 60 min.
  • a buffer solution of 0.0125 % acetic acid and 0.0125 % ammonium acetate was prepared by dissolving 0.125 g ammonium acetate and 125 ⁇ L glacial acetic acid in one liter of water.
  • the retention time of rebaudioside B was adjusted by varying the ratio of ammonium acetate to acetic acid while maintaining a total of 0.025 % of both combined. Increasing the amount of acetic acid decreased the retention time of rebaudioside B.
  • the mobile phase was prepared by mixing the buffer solution with acetonitrile to achieve a rebaudioside A retention time of 7.0 + 0.5 min. Initially, this was approximately 20 % buffer (200 mL of buffer and 800 mL of acetonitrile). Increasing the amount of acetonitrile by 1 to 2 % increased the retention time of rebaudioside A by about one minute.
  • a diluent solution was prepared by mixing 750 niL of acetonitrile and 250 mL of the buffer solution.
  • Rebaudioside A standards were prepared by diluting 20.0 + 0.5 mg (recorded to the nearest 0.1 mg) of the rebaudioside A standard with 4 mL of the diluent solution to make a standard solution of approximately 5000 mg/L.
  • the rebaudioside A standard solution was injected at 10.8, 11.4, 12.6 and 13.2 ⁇ L.
  • the moisture content was measured by Karl Fischer analysis every time a standard was prepared and corrections were made based on the solvent purity according to the certificate of analysis.
  • rebaudioside A standards were prepared by diluting individual samples of 18, 19, 21 and 22 (each + 0.2) mg of rebaudioside A standard with 4 mL of the diluent solution (correcting for moisture and purity). The individually prepared samples were injected at the same level as the samples (12 ⁇ L).
  • Stevioside standards were prepared by diluting 12.5 ⁇ 0.5 mg (recorded to the nearest 0.1 mg) of the stevioside standard with 5 mL of the diluent solution to make a standard solution of approximately 2500 mg/L standard (stock A) (correcting for moisture and purity). The stevioside standard was then diluted using one mL of stock A to ten mL of diluent to produce a 250 mg/L standard (stock B), and stock standards were diluted to final concentrations ranging from 2.5 to 50 mg/L.
  • Samples of the rebaudioside A compositions were prepared by diluting 125 + 2 mg (recorded to the nearest 0.1 mg) of the rebaudioside A composition with 25 mL of the diluent solution to make a sample solution of approximately 5000 mg/L (correcting for moisture). If the samples were not analyzed immediately, they were stored without headspace, under nitrogen, and desiccated.
  • Crude rebaudioside A (77.4 % purity) mixture was obtained from a commercial source.
  • the impurities (6.2 % stevioside, 5.6 % rebaudioside C 3 0.6 % rebaudioside F, 1.0 % other steviol glycosides, 3.0 % rebaudioside D, 4.9 % rebaudioside B, 0.3 % stevioibioside) were identified and quantified using HPLC on a dry basis (moisture content 4.7 %).
  • substantially pure rebaudioside A (130 g) comprised 98.91 % rebaudioside A, 0.06 % stevioside, 0.03 % rebaudioside C, 0.12 % rebaudioside F, 0.13 % other steviol glycosides, 0.1 % rebaudioside D, 0.49 % rebaudioside B and 0.03 % steviolbioside, all by weight.
  • the clear solution was cooled to 22°C for 16 hours.
  • the white crystals were filtered and washed twice with ethanol (2 x 50 mL, 95 %).
  • the wet filter cake (88 g) was slurried in ethanol (95 %, 1320 mL) for 16 hours, filtered, washed with ethanol (95 %, 2 x 100 mL) and dried in a vacuum oven at 60 0 C for 16-24 hours under reduced pressure (20 mm).
  • substantially pure rebaudioside A (72 g) comprised 98.29 % rebaudioside A, 0.03 % stevioside, 0.02 % rebaudioside C, 0.17 % rebaudioside F, 0.06 % rebaudioside D and 1.09 % rebaudioside B.
  • Steviolbioside was not detected by HPLC.
  • Crude rebaudioside A (80.37 %) was obtained from a commercial source.
  • the impurities (6.22 % stevioside, 2.28 % rebaudioside C, 0.35% dulcoside A, 0.78 % rebaudioside F, 0.72 % other steviol glycosides, 3.33 % rebaudioside B, 0.07 % steviolbioside) were identified and quantified by HPLC on a dry basis (moisture content 3.4 %).
  • the clear solution was cooled to 22°C for 16 hours.
  • the white crystals were filtered and washed twice with ethanol (2 x 25 mL, 95 % ).
  • the wet filter cake (40 g) was slurried in methanol (99 %, 600 niL) for 16 hours, filtered, washed with methanol (99 %, 2 x 25 mL) and dried in a vacuum oven at 60 0 C for 16-24 hours under reduced pressure (20 mm).
  • substantially pure rebaudioside A (27.3g) comprised 98.22 % rebaudioside A, 0.04 % stevioside, 0.04 % rebaudioside C, 0.18 % rebaudioside F, 0.08 % rebaudioside D and 1.03 % rebaudioside B.
  • Steviolbioside was not detected by HPLC.
  • the wet cake of white crystalline product was slurried in methanol (99.8 %, 350 mL) for 16 hours, filtered, washed twice with methanol (99.8 %, 25 mL) and dried in a vacuum oven at 60 0 C for 16-24 hours under reduced pressure (20 mm) to yield 22.2 g of purified product (> 97 % by HPLC).
  • EXAMPLE F A solution of substantially pure rebaudioside A obtained using the purification technique described hereinabove ( >97 % pure by HPLC ) was prepared in double distilled water (12.5 gm in 50 mL, 25 % concentration) by stirring the mixture at 40 0 C for 5 minutes. An amorphous form of rebaudioside A was formed by immediately using the clear solution for spray drying with the Lab-Plant spray drier SD-04 instrument (Lab-Plant Ltd., West Yorkshire, U.K.). The solution was fed through the feed pump into the nozzle atomizer, which atomized the rebaudioside A solution into a spray of droplets with the help of a constant flow of nitrogen / air.
  • This dry powder (11-12 g, H 2 O 6.74 %) was discharged continuously from the drying chamber and was collected in a bottle. The rate of dissolution in water at room temperature was determined to be > 35.0 %.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Saccharide Compounds (AREA)
  • Seasonings (AREA)

Abstract

Exemplary embodiments of this invention encompass a method for purifying crude rebaudioside A. In particular, this invention relates to a method for purifying crude rebaudioside A compositions comprising purities from approximately 40 % to approximately 95 % rebaudioside A to obtain a substantially pure rebaudioside A product with a single crystallization step. Resulting polymorph and amorphous forms of rebaudioside A and methods for preparing polymorph and amorphous forms of rebaudioside A from crude rebaudioside A compositions and substantially pure rebaudioside A compositions also are disclosed.

Description

REBAUDIOSIDE A COMPOSITION AND METHOD FOR PURIFYING REBAUDIOSIDE A
FIELD OF INVENTION
This invention relates generally to polymorphic and amorphous forms of rebaudioside A, methods for purifying rebaudioside A, and methods for preparing polymorphic and amorphous forms of rebaudioside A. More particularly, this invention relates to polymorphic and amorphous forms of rebaudioside A and methods for the purification or crystallization of rebaudioside A with aqueous organic solvents or organic solvents to obtain a product in high yield and high purity.
BACKGROUND OF INVENTION
Rebaudioside A is a high-potency diterpenoid glycoside sweetener having the chemical structure:
Figure imgf000002_0001
Rebaudioside A is isolated and extracted, along with other steviol glycosides, from the Stevia rebaudiana (Bertoni) plant ("Stevia"), which is commercially cultivated in Japan, Singapore, Taiwan, Malaysia, South Korea, China, Israel, India, Brazil, Australia, and Paraguay. It is an alternative non-caloric sweetener with functional and sensory properties superior to those of many high-potency sweeteners. Processed forms of Stevia can be 70 to 400 times more potent than sugar; however, Slevia also has a bitter component. Of the four major diterpenoid glycoside sweeteners present in Stevia, rebaudioside A has been identified as the least bitter, and with the least persistent aftertaste. Bitterness often is significantly due to the impurities in extracts.
Rebaudioside A is generally available at < 80 % pure. The primary impurities comprise stevioside, steviolbioside, rebaudioside B, rebaudioside C, rebaudioside D, dulcoside A, rebaudioside F, and other steviol glycosides. It is very difficult to obtain a high purity of rebaudioside A in high recovery because the rebaudioside A and the impurities have similar solubilities.
Previously reported efforts to purify rebaudioside A from mixtures of rebaudioside A and stevioside require numerous repeated purification steps. U.S. Patent No. 5,962,678 discloses the re-crystallization of rebaudioside A using an anhydrous methanol solution to obtain an 80 % pure rebaudioside A. By repeating the re-crystal iization with anhydrous methanol numerous times, the purity of rebaudioside A may be increased to over 95 %. U.S. Patent Publication No. 2006/0083838 discloses purification of rebaudioside A through re-crystallization with a solvent comprising ethanol and between 4 and 15 % water. Japanese Patent Application No. 55-23756 discloses a method for purifying rebaudioside A and stevioside by crystallization from aqueous ethanol (> 70 %) to obtain an 80 % pure rebaudioside A. U.S. Patent Publication No. 2007/0082103 discloses a method for purifying rebaudioside A by recrystallization from aqueous ethanol, asserting a two-step recrystal Iization from crude rebaudioside (60 %) results in the formation of > 98 % pure rebaudioside at 97 % yield. These prior art methods, however, do not provide a substantially pure rebaudioside A composition using only a single recrystallization step.
Accordingly, there exists a need for a simple, efficient, and economical method for producing substantially pure rebaudioside A.
SUMMARY OF INVENTION
Exemplary embodiments of the invention address the above- identified need by providing a substantially pure rebaudioside A, polymorphic and amorphous forms of rebaudioside A, methods for purifying rebaudioside A, and methods for making polymorphic and amorphous forms of rebaudioside A.
In a particular embodiment, the method for purifying rebaudioside A comprises a simple crystallization. In one embodiment, a method for purifying rebaudioside A comprises combining crude rebaudioside A and an aqueous organic solvent to form a rebaudioside A solution, the aqueous organic solution comprising water in an amount from about 10 % to about 25 % by weight, and crystallizing from the crude rebaudioside A solution, in a single step, a substantially pure rebaudioside A in a purity greater than about 95% by weight on a dry basis. In other particular embodiments, different polymorphic and amorphous forms of rebaudioside A and methods for preparing different polymorphic and amorphous forms of rebaudioside A are provided.
Other objects, features, and advantages of the invention will be apparent from the following detailed description, drawings, and claims. Unless otherwise defined, all technical and scientific terms and abbreviations used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention pertains. Although methods and compositions similar or equivalent to those described herein can be used in the practice of the present invention, suitable methods and compositions are described without intending that any such methods and compositions limit the invention herein.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a schematic illustrating a method for purifying rebaudioside A in accordance with an embodiment of this invention.
Fig. 2 is a schematic of the formation and conversion of rebaudioside A polymorphic and amorphous forms of rebaudioside A in accordance with an embodiment of this invention.
Fig. 3 is a powder x-ray diffraction scan comparing four rebaudioside A polymorphs, Forms 1, 2, 3A and 3B, on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention. Fig. 4 is a powder x-ray diffraction scan comparing rebaudioside A polymorphs, Form 1 and Form 2, on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention.
Fig. 5 is a powder x-ray diffraction scan comparing rebaudioside A polymorphs, Form 3 A and Form 3B, on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention.
Fig. 6 is a powder x-ray diffraction scan comparing rebaudioside A polymorphs, Forms 2, 3 A and 3B, on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention, Fig. 7 is a powder x-ray diffraction scan of rebaudioside A polymorph Form I on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention.
Fig. 8 is a powder x-ray diffraction scan of rebaudioside A polymorph Form 2 on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention.
Fig. 9 is a powder x-ray diffraction scan of rebaudioside A polymorph Form 3A on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention.
Fig. 10 is a powder x-ray diffraction scan of rebaudioside A polymorph Form 3B on a plot of the scattering intensity versus the scattering angle 2Θ in accordance with an embodiment of this invention.
Fig. 1 1 is a powder x-ray diffraction scan of rebaudioside A amorphous Form 4 on a plot of the scattering intensity versus the scattering angle 20 in accordance with an embodiment of this invention. DETAILED DESCRIPTION OF INVENTION
Rebaudioside A is a natural high-potency sweetener that generally is available at moderate cost at < 80% purity and at > 80 % purity only at high cost. Commercial samples of rebaudioside A often have a bitter taste that is believed to be due to impurities. Accordingly, there exists a need for a substantially pure rebaudioside A and a simple and economic method for purifying rebaudioside A in order to obtain a substantially pure rebaudioside A suitable for use as a natural high-potency sweetener.
As used herein, the term "substantially" or "substantially pure" refers to a rebaudioside A composition that includes at least about 85 % by dry weight of the rebaudioside A, in another embodiment at least about 90 % by dry weight, in another embodiment from about 95 % to about 98 % by dry weight, and in yet another embodiment from about 99 % to about 100 % by dry weight.
Exemplary embodiments of this invention satisfy these needs by providing a method for purifying crude rebaudioside A to substantially pure rebaudioside A by crystallizing a crude rebaudioside A from an aqueous organic solution comprising water in an amount from about 10 % to about 25 % by weight and crystallizing in at least one step a substantially pure rebaudioside A. Other exemplary embodiments of this invention encompass a composition of a substantially pure rebaudioside A and compositions comprising one, or more than one, polymorph(s) of rebaudioside A. Still other exemplary embodiments of this invention encompass an amorphous form of rebaudioside A and methods of preparing amorphous forms of rebaudioside A. In yet another embodiment, a method for converting one form of polymorph into another form of polymorph or amorphous form is provided. Exemplary embodiments of this invention are described in detail below and illustrated in Figures 1-11. Method of Purifying Crude Rebaudioside A Mixture
Crude rebaudioside A products are commercially available comprising rebaudioside A in purities from about 40 % to about 95 % by weight, about 60 % to about 85 % by weight, or about 70 % to about 85 % by weight. It is envisioned that crude rebaudioside A in its raw form as extracted from Stevia plants, may be purified by recrystallization. The primary impurities, identified by HPLC, are stevioside, rebaudioside B, rebaudioside C, and rebaudioside D. Rebaudioside D impurities can be removed by increasing the amount of water in an aqueous organic recrystallization solvent; however, excessive water content in the crystallization solvent will result in a lower recovery of rebaudioside A. Rebaudioside B impurity can be reduced significantly by slurrying the crude rebaudioside A in an organic solvent or an aqueous organic solution or through treatment of the crude rebaudioside A solution with an anion exchange resin. Accordingly, the method of purification depends on the impurities present in the crude rebaudioside A starting material.
In an exemplary embodiment of a method for purifying rebaudioside A 110, illustrated in Figure 1, crude rebaudioside A 112 may be combined 114 with an aqueous organic solution 116 to form a rebaudioside A solution 118. The aqueous organic solution 116 comprises water in an amount from about 10 % to about 25 % by weight and at least one organic solvent. Alternatively, the aqueous organic solution 116 may comprise water in an amount from about 15 % to about 20 % by weight and at least one organic solvent. Aqueous organic solvents, as used herein, refer to mixtures of water and at ieast one organic solvent. Non-limiting examples of organic solvents include alcohol, acetone, and acetonitrile. Alcohol, as used herein, refers to any straight, branched, or cyclic; substituted or unsubstituted alkyl, alkenyl, or alkynyl group attached to at least one hydroxyl moiety. Non-limiting examples of alcohols include ethanol, methanol, isopropanol, 1-propanol, 1-butanol, 2-butanol, tert-butanol, and isobutanol.
In an exemplary embodiment, the aqueous organic solution 116 comprises a mixture of water and at least one organic solvent. In another exemplary embodiment, at least one organic solvent comprises an alcohol, the alcohol comprising ethanol, methanol, or mixtures thereof. In exemplary embodiments wherein the at least one organic solvent comprises a mixture of ethanol and methanol, the ethanol and methanol may be combined in the aqueous organic solvent in a weight ratio ranging from about 20 parts to about 1 part ethanol to about 1 part methanol. In another exemplary embodiment, the ethanol and methanol may be combined in the aqueous organic solvent in a weight ratio ranging from about 3 parts to about 1 part ethanol to about 1 part methanol.
In an exemplary embodiment, the rebaudioside A solution 1 18 comprises the aqueous organic solvent 116 and the crude rebaudioside A 112 in a weight ratio ranging from about 10 to about 4 parts aqueous organic solvent to about 1 part crude rebaudioside A. In another exemplary embodiment, the rebaudioside A solution 118 comprises the aqueous organic solution 116 and the crude rebaudioside A 112 in a weight ratio ranging from about 5 to about 3 parts aqueous organic solvent to about 1 part crude rebaudioside A.
In an exemplary embodiment, the method 1 10 may be carried out at approximately room temperature. In another embodiment, the method 110 further comprises the step of heating 120 the rebaudioside A solution 118. In an embodiment, the step of heating 120 the rebaudioside A solution 118 comprises heating the rebaudioside A solution to a temperature in a range from about 20°C to about 70°C, from about 20°C to about 6O0C, from about 20°C to about 40°C, or from about 40°C to about 60°C. In another embodiment, the step of heating 120 the rebaudioside A solution 1 18 comprises heating the rebaudioside A solution to about reflux temperature. The step of heating 120 the rebaudioside A solution 118 comprises heating the rebaudioside A solution for about 0.25 hours to about 8 hours. In another exemplary embodiment, wherein the method for purifying rebaudioside A I lO comprises the step of heating 120 the rebaudioside A solution 118, the method further comprises the step of cooling 122 the rebaudioside A solution. In an embodiment, the step of cooling 122 the rebaudioside A solution 118 comprises cooling the rebaudioside A solution to a temperature in the range from about 4°C to about 25°C. The step of cooling 122 the rebaudioside A solution 1 18 comprises cooling the rebaudioside A solution for about 0.5 hours to about 24 hours. The method for purifying rebaudioside A 1 10 further comprises the step of crystallizing 124 from the rebaudioside A solution 118 in a single step a substantially pure rebaudioside A composition 126 comprising rebaudioside A in an amount greater than about 85 % by weight on a dry basis, greater than about 90 % by weight on a dry basis, greater than about 95 % by weight on a dry basis, greater than about 97 % by weight on a dry basis, greater than about 98 % by weight on a dry basis, or greater than about 99 % by weight on a dry basis. The rebaudioside A solution 118 during the single crystal ϋzation step may be stirred or unstirred.
In an exemplary embodiment, the method 110 may further comprise the optional step of seeding 128 the rebaudioside A solution 1 18 at an appropriate temperature with substantially pure crystals of rebaudioside A 130 sufficient to promote crystallization of the rebaudioside A to form pure rebaudioside A. An amount of rebaudioside A 130 sufficient to promote crystallization of substantially pure rebaudioside A 126 comprises an amount of rebaudioside A from about 0.0001 % to about 1 % by weight of the rebaudioside A present in the solution. In another embodiment, an amount of rebaudioside A 130 sufficient to promote crystallization of the rebaudioside A to form a composition of a substantially pure rebaudioside A 126 comprises an amount of rebaudioside A from about 0.01 % to about 1 % by weight. An appropriate temperature for the step of seeding 128 comprises a temperature in a range from about 18"C to about 350C.
In another exemplary embodiment, the method further comprises the steps of separating 132 and washing 134 the substantially pure rebaudioside A composition 126. The substantially pure rebaudioside A composition 126 may be separated from the aqueous organic solution 118 by a variety of solid-liquid separation techniques that utilize centrifugal force, that include, without limitation, vertical and horizontal perforated basket centrifuge, solid bowl centrifuge, decanter centrifuge, peeler type centrifuge, pusher type centrifuge, Heinkel type centrifuge, disc stack centrifuge and cyclone separation. Additionally, separation may be enhanced by any pressure, vacuum, or gravity filtration methods, that include without limitation, the use of belt, drum, nutsche type, leaf, plate, Rosenmund type, sparkler type, and bag filters and filter press. Operation of the rebaudioside A solid-liquid separation device may be continuous, semi -continuous or in batch mode. The substantially pure rebaudioside A composition 126 also may be washed 134 on the separation device using various aqueous organic solvents 136 and mixtures thereof. The substantially pure rebaudioside A composition 126 can be partially or totally dried on the separation device using any number of gases, including, without limitation, nitrogen or argon, to evaporate residual liquid solvent 136. The substantially pure rebaudioside A composition 126 may be automatically or manually removed from the separation device using liquids, gases or mechanical means by either dissolving the solid or maintaining the solid form.
In still another exemplary embodiment, the method 110 further comprises the step of drying 138 the substantially pure rebaudioside A composition 126. Such methods are known to those skilled in the art and include, but are not limited to, the use of a rotary vacuum dryer, fluid bed dryer, rotary tunnel dryer, plate dryer, tray dryer,
Nauta type dryer, spray dryer, flash dryer, micron dryer, pan dryer, high and low speed paddle dryer and microwave dryer, In an exemplary embodiment, the step of drying 138 comprises drying the substantially pure rebaudioside A composition 126 using a nitrogen or argon purge to remove the residual solvent 120 at a temperature in a range from about 4O0C to about 60°C for about 5 hours to about 100 hours. In yet another exemplary embodiment, wherein the crude rebaudioside A mixture 112 comprises substantially no rebaudioside D impurity, the method 110 further comprises the step of slurrying 140 the composition of substantially pure rebaudioside A 126 with an organic solvent or an aqueous organic solvent 142 prior to the step of drying 138 the substantially pure rebaudioside A composition. The slurry may be a mixture comprising a solid and an aqueous organic solvent or organic solvent, wherein the solid comprises the substantially pure rebaudioside A composition 126 and is only sparingly soluble in the aqueous organic solvent or organic solvent 142. In an embodiment, the substantially pure rebaudioside A composition 126 and aqueous organic solvent or organic solvent 142 may be present in the slurry in a weight ratio ranging from about 15 parts to about 1 part aqueous organic solvent to about 1 part substantially pure rebaudioside A composition. In one embodiment, the slurry may be maintained at room temperature. In another embodiment, the step of slurrying 140 comprises heating the slurry to a temperature in a range from about 20°C to about 40°C. The substantially pure rebaudioside A composition 126 may be slurried for about 0.5 hours to about 24 hours.
In still yet another exemplary embodiment, the method further comprises the steps of separating 132 the substantially pure rebaudioside A composition 126 from the aqueous organic solvent 142 of the slurry and washing 134 the substantially pure rebaudioside A composition followed by the step of drying 138 the substantially pure rebaudioside A composition.
If further purification is desired, the method of purifying rebaudioside A 110 described herein may be repeated or the substantially pure rebaudioside A composition may be further purified using an alternative purification method, such as the column chromatography. Purity, as used herein, represents the weight percentage of rebaudioside A present in a rebaudioside A composition in raw or purified form. In one embodiment, a rebaudioside A composition comprises rebaυdioside A in a particular purity, with the remainder of the composition comprising a mixture of other steviol glycosides or any component that is not rebaudioside A. The purity of the composition may be measured using methods known to those of ordinary skill in the art. One such method includes high performance liquid chromatography (HPLC). Those of ordinary skill in the art also should appreciate that the moisture in the sample may affect the accuracy of purity measurements. Accordingly, the composition should be substantially dry when measured for purity. As used herein, a substantially dry composition comprises up to about 10 % by weight of moisture. Rebaudioside A Polymorphic and Amorphous Forms
The purification of rebaudioside A using the method described hereinabove results in the formation of at least three different polymorphs of rebaudioside A: Form 1 : a rebaudioside A hydrate; Form 2: an anhydrous rebaudioside A, and Form 3: a rebaudioside A solvate. Those of ordinary skill in the art will appreciate that both the aqueous organic solution and the temperatures of the purification process described herein may influence the resulting polymorphs of a substantially pure rebaudioside A composition.
Polymorphism is defined as the ability of a substance to exist as two or more crystalline states that have different arrangements and/or conformations of the molecules in the crystal lattice. Approximately 30 % of organic compounds are believed to exhibit polymorphism (ZeIl, et al, Tetrahedron 56(36)6603-16 (2000)). Polymorphism is important in the formulation of pharmaceuticals, pigments and dyes, sweeteners, explosives, and agrochemicals. Polymorphism may cause physical properties such as density, melting point, and rate of dissolution to change. The polymorphs of rebaudioside A were identified by analysis of samples with powder x-ray diffraction (XRPD), a technique well known to those skilled in the art. Figs. 3-11 are XRPD scans of substantially pure rebaudioside A compositions obtained from the purification process described herein. The XRPD scans of rebaudioside A polymorphs were created by plotting the scattering intensity versus the scattering angle 2Θ. Samples were analyzed by XRPD using a Shimadzu XRD-6000 X-ray powder diffractometer using Cu Ka radiation. The instrument was equipped with a long fine focus X-ray tube. The tube voltage and amperage were set to 40 kV and 40 mA, respectively. The divergence and scattering slits were set at 1°, and the receiving slit was set at 0.15 mm. Diffracted radiation was detected by a NaI scintillation detector. A Θ-2Θ continuous scan at 37min (0.4 sec/0.02o step) from 2.5 to 40° 20 was used. A silicon standard was analyzed to check the instrument alignment. Data were collected and analyzed using XRD-60000 v. 4.1. The patterns exhibit resolution of reflections, indicating that the samples are comprised of crystalline material.
Fig. 3 shows representative patterns for Form 1, Form 2, and Forms 3 A (methanol solvate) and 3B (ethanol solvate). The pattern for Form 2 (top pattern) is distinctively different from the other patterns. It should be noted that multiple polymorphs can exist within each classification of Forms 1, 2, and 3.
Fig. 4 highlights the differences between Forms 1 and 2. Additionally, the two patterns of Form 2 are shown to illustrate the reproducibility in generation of the different polymorphs under varying recrystallization conditions of the polymorphs. Fig. 5 shows a significant similarity between the XRPD patterns of Forms 3 A and 3B. Not wishing to be bound by any theory, it is possible that these polymorphs are isostructural solvates, wherein the only differences between the patterns are the shifting of certain peaks due to the variation of the solvent identity. This isostructural relationship between Forms 3A and 3B could be verified by indexing the patterns if necessary. The asterisks identify the peaks that are shifted to the right by about 0.2 degrees 2Θ in the pattern for Form 3A, In addition, several peaks in Form 3B are more intense than the corresponding peaks in Form 3A. For example, the peaks at 5,5, 11.0, 14.2. and 19.4 degrees are more intense for Form 3B than for Form 3 A.
Fig. 6 compares Form 2 to Forms 3 A and 3B from Fig. 5. Form 2 is more similar to Form 3 A than to that of Form 3B. Although the peaks identified in Fig. 5 as being more intense in Form 3 B than in Form 3 A are not observed in the pattern of
Form 2, there are at least three peaks (marked with a double-asterisks underneath the patterns) that show the reverse trend (i.e., the peaks are present in Form 2, small in
Form 3A, and larger in Form 3B). Finally, a large peak in Form 3B at 17.6 degrees appears to be shifted slightly to the right in Form 3A (17.9 degrees) and shifted further to the right in Form 2 (18.0 degrees). Two other sets of peaks between 21 and 23 degrees show this shifting as well. Not wishing to be bound by any theory, the shifting of the peaks may be an indication that Form 3 A is partially desolvated, thus containing a mixture of both the solvate and Form 2 crystals.
Figs. 7-10 are XRPD scans of the individual polymorphs Form 1, Form 2, Form 3A, and Form 3B5 respectively, from a substantially pure rebaudioside A composition obtained from the purification process described hereinabove.
As illustrated in Fig. 2, the type of polymorph formed may be dependent on the factors such as the composition of the aqueous organic solution, the temperature of the crystallization step, and the temperature during the drying step. Not wishing to be bound by any theory, Form 1 and Form 3 are believed to be formed during the single crystallization step while Form 2 is believed to be formed during the drying step after conversion from Form 1 and Form 3.
Low temperatures during the crystallization step, in the range of about 20°C to about 50°C, and a low ratio of water to the organic solvent in the aqueous organic solvent results in the formation of Form 3. High temperatures during the crystallization step, in the range of about 500C to about 80°C, and a high ratio of water to the organic solvent in the aqueous organic solvent results in the formation of the Form 1. Form 1 can be converted to Form 3 by slurrying in an anhydrous solvent at about room temperature for about 2 to about 16 hours or by slurrying in an anhydrous solvent at about reflux temperature for about 0,5 to about 3 hours. Form 3 can be converted to Form 1 by slurrying the polymorph in water at about room temperature for approximately 16 hours or at about reflux temperature for about 2 to about 3 hours. Form 3 can be converted to the Form 2 during the drying process; however, increasing either the drying temperature above about 70°C or the drying time of a substantially pure rebaudioside A composition can result in decomposition of the rebaudioside A and increase the remaining rebaudioside B impurity in the substantially pure rebaudioside A composition. Form 2 can be converted to Form 1 with the addition of water.
In addition to the at least three polymorphic forms of rebaudioside A, the purification of rebaudioside A may result in the formation of an amorphous form of rebaudioside A, Form 4, as shown in Fig. 1 1. Form 4 has a broad amorphous halo that identifies the composition as being amorphous. Amorphous, as used herein, describes a non-crystalline solid material. The amorphous form of rebaudioside A (Form 4) has an improved rate of dissolution as compared to the polymorphic forms of rebaudioside A (Forms 1, 2, or 3). Those of ordinary skill in the art should appreciate that the rate of dissolution of a sweetener composition may be important in the formulation of solid and liquid sweetenable compositions, non-Hrniting examples of which include chewing gum, baked goods, and beverages.
As described hereinabove, Form 4 may be obtained during the initial purification of rebaudioside A or directly from any individual polymorph or combination of polymorphs using methods well known to those of ordinary skill in the art. In addition, Form 4 may be obtained from a crude rebaudioside A composition or a substantially pure rebaudioside A composition obtained through purification means other than those described hereinabove. Non-limiting examples of methods for preparing amorphous forms of rebaudioside A include ball milling, precipitation, iyophilization, cryogrinding, and spray-drying of a rebaudioside A composition.
In a particular embodiment, the purification of rebaudioside A described hereinabove results in a composition comprising the amorphous rebaudioside A of Form 4. Those of ordinary skill in the art should appreciate that the parameters of the crystallization procedure may be modified to enhance the formation of Form 4. In another particular embodiment, Form 4 can be prepared from a rebaudioside
A composition by spray-drying a solution of the rebaudioside A composition. Briefly described, spray-drying generally requires the feed of a solution of rebaudioside A through a feed pump into a nozzle atomizer which atomizes the solution into a spray of droplets with the help of a constant flow of nitrogen/air. The moisture is evaporated from the droplets under controlled temperature conditions and airflow conditions in the drying chamber, resulting in the formation of dry particles of amorphous rebaudioside A. The purity of the amorphous rebaudioside A will depend upon the purity of the solution of rebaudioside A .
In another particular embodiment, Form 4 can be prepared from a rebaudioside A composition by milling non-amorphous forms of rebaudioside A. Milling is a mechanical process that is believed to produce localized areas of energy that convert crystalline forms of rebaudioside A to the amorphous form. Exemplary milling techniques include baϊt milling or air jet milling, both techniques well known to those of ordinary skill in the art. Briefly described, non-amorphous forms of rebaudioside A are milled for a period of time and at a speed effective to form an amorphous rebaudioside A. These parameters may be determined by those of ordinary skill in the art. Typical milling time periods may range from about 15 minutes to about 2 hours, although other time periods also may be employed.
The material properties of the three rebaudioside A polymorphs and the rebaudioside A amorphous form are summarized in the following table:
Table 1 : Rebaudioside A Polymorph and Amorphous Forms
Figure imgf000015_0001
The above-described material properties are only illustrative of particular embodiments of the polymorphic and amorphous forms of rebaudioside A. Those of ordinary skill in the art should appreciate that the anhydrous rebaudioside A polymorph (Form 2), rebaudioside A solvate polymorph, and amorphous rebaudioside A are hygroscopic and may absorb moisture to an amount up to about 10 % by weight on a dry basis.
Those of ordinary skill in the art should appreciate that the rebaudioside A composition may be modified to obtain a desired mixture of rebaudioside A polymorphic and amorphous forms depending on the desired qualities of the rebaudioside A composition (i.e., rate of dissolution, etc.). In one embodiment, a substantially pure rebaudioside A composition may comprise a particular polymorphic or amorphous form of rebaudioside A in an amount in the range of about 1 % to about 100 % by weight. For example, a substantially pure rebaudioside A composition may comprise a polymorphic or amorphous form of rebaudioside A in an amount greater than about 25 % by weight, more particularly in an amount greater than about 50 % by weight, still more particularly in an amount greater than about 75 % by weight, or still even more particularly in an amount greater than about 85 % by weight. Suitable amounts of rebaudioside A polymorphic or amorphous forms also may be used within these ranges. In another embodiment, a substantially pure rebaudioside A composition may comprise a combination of particular polymorphic and/or amorphous form of rebaudioside A.
The present invention is further illustrated by the following examples, which are not to be construed in any way as imposing limitations upon the scope thereof. On the contrary, it is to be clearly understood that resort may be had to various other embodiments, modifications, and equivalents thereof which, after reading the description therein, may suggest themselves to those skilled in the art without departing from the spirit of the present invention and/or the scope of the appended claims. Unless otherwise specified, percentages (%s) are by weight.
EXAMPLES
The purity of the rebaudioside A compositions described in the examples hereinbelow was determined using HPLC. Methods of performing HPLC analysis are well known to those of ordinary skill in the art. Briefly described, the HPLC analysis was performed using a ZORBAX NH2 column (150 x 4.6 mm, 5 μm) at a temperature of 300C. The mobile phase comprised a solution of 20 % buffer (0.0125 % acetic acid and 0.0125 % ammonium acetate) and 80 % acetonitrile at a flow rate of 1.5 mL/min, 12 μL of each sample was injected in duplicate and the sample was analyzed using a UV detector at 210 nm (4 nm bandwidth) with a reference of 260 nm (100 ran bandwidth). The HPLC analysis required a run time ranging from 40 to 60 min.
A buffer solution of 0.0125 % acetic acid and 0.0125 % ammonium acetate was prepared by dissolving 0.125 g ammonium acetate and 125 μL glacial acetic acid in one liter of water. The retention time of rebaudioside B was adjusted by varying the ratio of ammonium acetate to acetic acid while maintaining a total of 0.025 % of both combined. Increasing the amount of acetic acid decreased the retention time of rebaudioside B.
The mobile phase was prepared by mixing the buffer solution with acetonitrile to achieve a rebaudioside A retention time of 7.0 + 0.5 min. Initially, this was approximately 20 % buffer (200 mL of buffer and 800 mL of acetonitrile). Increasing the amount of acetonitrile by 1 to 2 % increased the retention time of rebaudioside A by about one minute. A diluent solution was prepared by mixing 750 niL of acetonitrile and 250 mL of the buffer solution. Rebaudioside A standards were prepared by diluting 20.0 + 0.5 mg (recorded to the nearest 0.1 mg) of the rebaudioside A standard with 4 mL of the diluent solution to make a standard solution of approximately 5000 mg/L. The rebaudioside A standard solution was injected at 10.8, 11.4, 12.6 and 13.2 μL. The moisture content was measured by Karl Fischer analysis every time a standard was prepared and corrections were made based on the solvent purity according to the certificate of analysis. Alternatively, rebaudioside A standards were prepared by diluting individual samples of 18, 19, 21 and 22 (each + 0.2) mg of rebaudioside A standard with 4 mL of the diluent solution (correcting for moisture and purity). The individually prepared samples were injected at the same level as the samples (12 μL).
Stevioside standards were prepared by diluting 12.5 ± 0.5 mg (recorded to the nearest 0.1 mg) of the stevioside standard with 5 mL of the diluent solution to make a standard solution of approximately 2500 mg/L standard (stock A) (correcting for moisture and purity). The stevioside standard was then diluted using one mL of stock A to ten mL of diluent to produce a 250 mg/L standard (stock B), and stock standards were diluted to final concentrations ranging from 2.5 to 50 mg/L.
Samples of the rebaudioside A compositions were prepared by diluting 125 + 2 mg (recorded to the nearest 0.1 mg) of the rebaudioside A composition with 25 mL of the diluent solution to make a sample solution of approximately 5000 mg/L (correcting for moisture). If the samples were not analyzed immediately, they were stored without headspace, under nitrogen, and desiccated.
The following table provides a guideline for retention times (RT) for rebaudioside A and other steviol glycosides. However, those of ordinary skill in the art should appreciate that the retention times may be modified as needed.
Table 2: HPLC Retention Guidelines
Figure imgf000018_0001
EXAMPLE SET A Table 3: Summary of Examples A 1-3
Figure imgf000018_0002
EXAMPLE Al
Crude rebaudioside A (77.4 % purity) mixture was obtained from a commercial source. The impurities (6.2 % stevioside, 5.6 % rebaudioside C3 0.6 % rebaudioside F, 1.0 % other steviol glycosides, 3.0 % rebaudioside D, 4.9 % rebaudioside B, 0.3 % stevioibioside) were identified and quantified using HPLC on a dry basis (moisture content 4.7 %).
Crude rebaudioside A (400 g), ethanol (95 %, 1200 mL), methanol (99 %, 400 mL) and water (320 mL) were combined and heated to 500C for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystals were filtered and washed twice with ethanol (2 x 200 mL, 95%) and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm).
The final composition of substantially pure rebaudioside A (130 g) comprised 98.91 % rebaudioside A, 0.06 % stevioside, 0.03 % rebaudioside C, 0.12 % rebaudioside F, 0.13 % other steviol glycosides, 0.1 % rebaudioside D, 0.49 % rebaudioside B and 0.03 % steviolbioside, all by weight.
EXAMPLE A2 Crude rebaudioside A (80.37 %) was obtained from a commercial source. The impurities (6.22 % stevioside, 2.28 % rebaudioside C7 0.35 % dulcoside A, 0.78 % rebaudioside F, 0.72 % other steviol glycosides, 3.33 % rebaudioside B, 0.07 % steviolbioside) were identified and quantified by HPLC on a dry basis (moisture content 3.4 %). Crude rebaudioside A (100 g), ethanol (95%, 320 mL), methanol (99%, 120 mL) and water (50 mL) were combined and heated to 30-400C for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystals were filtered and washed twice with ethanol (2 x 50 mL, 95 %). The wet filter cake (88 g) was slurried in ethanol (95 %, 1320 mL) for 16 hours, filtered, washed with ethanol (95 %, 2 x 100 mL) and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm).
The final composition of substantially pure rebaudioside A (72 g) comprised 98.29 % rebaudioside A, 0.03 % stevioside, 0.02 % rebaudioside C, 0.17 % rebaudioside F, 0.06 % rebaudioside D and 1.09 % rebaudioside B. Steviolbioside was not detected by HPLC.
EXAMPLE A3
Crude rebaudioside A (80.37 %) was obtained from a commercial source. The impurities (6.22 % stevioside, 2.28 % rebaudioside C, 0.35% dulcoside A, 0.78 % rebaudioside F, 0.72 % other steviol glycosides, 3.33 % rebaudioside B, 0.07 % steviolbioside) were identified and quantified by HPLC on a dry basis (moisture content 3.4 %).
Crude rebaudioside A (50 g), ethanol (95 %, 160 mL), methanol (99 %, 60 mL) and water (25 mL) were combined and heated to approximately 300C for 10 minutes.
The clear solution was cooled to 22°C for 16 hours. The white crystals were filtered and washed twice with ethanol (2 x 25 mL, 95 % ). The wet filter cake (40 g) was slurried in methanol (99 %, 600 niL) for 16 hours, filtered, washed with methanol (99 %, 2 x 25 mL) and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm).
The final composition of substantially pure rebaudioside A (27.3g) comprised 98.22 % rebaudioside A, 0.04 % stevioside, 0.04 % rebaudioside C, 0.18 % rebaudioside F, 0.08 % rebaudioside D and 1.03 % rebaudioside B. Steviolbioside was not detected by HPLC.
EXAMPLE SET B Table 4: Summar of Exam les Bl-19
Figure imgf000020_0001
EXAMPLE Bl
Crude rebaudioside A (77.4 % purity, 5 g), ethanol (95 %, 16 niL), methanol (6 ml) and water (2 niL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanokmethanol (5 mL, 4:1.5, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 97 % by HPLC).
EXAMPLE B2
Crude rebaudioside A (77.4 % purity, 5 g), ethanol (95 %, 16 mL), methanol (4 mL) and water (2 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanokmethanol (5 mL, 4:1, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 3.1 g of purified product (> 97 % by HPLC). EXAMPLE B 3
Crude rebaudioside A (77.4 % purity, 5 g), ethanol (95 %, 9.5 mL), 1-butanol (9.5 mL) and water (1 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol: 1-butanol (5 mL, 1: 1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 95 % by HPLC).
EXAMPLE B4
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 9.5 mL), methanol (9 mL) and water (1 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol: methanol (5 mL, 1 :1, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 3.5 g of purified product (> 96 % by HPLC). EXAMPLE B5
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 12.5 mL), methanol (6 mL) and water (2 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C. The solution was seeded with 10 mg of 98 % pure rebaudioside A and the mixture was left at 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol:methanol ( 5 mL, 4:1, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 3.3 g of purified product (> 97 % by HPLC).
EXAMPLE B6 Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 12.5 mL), acetonitrile (6 mL) and water (1.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C. The solution was seeded with 10 mg of 98 % pure rebaudioside A and the mixture was left at 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol:acetonitrile (5 mL, 6:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.4 g of purified product (> 95 % by HPLC).
EXAMPLE B7
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 14.5 mL), ethyl acetate (4 mL) and water (1.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C. The solution was seeded with 10 mg of 98 % pure rebaudioside A and the mixture was left at 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanohacetonitrile (5 mL, 7:2, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 3.4 g of purified product (> 95 % by HPLC). EXAMPLE B8
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol (6 mL) and water (2 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol methanol (5.5 mL, 4: 1.5, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 97 % by HPLC).
EXAMPLE B9
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol (4 mL) and water (2 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol: methanol (5.0 mL, 4:1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.1 g of purified product (> 97 % by HPLC). EXAMPLE BlO
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 14.5 mL), methanol (4 mL) and water (1.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol :methanol (5.0 mL, 7:2, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.4 g of purified product (> 97 % by HPLC).
EXAMPLE BI l
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol (6 mL) and water (1.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours. The white crystalline product was filtered, washed twice with ethanol: methanol (5.0 mL, 8:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 97 % by HPLC).
EXAMPLE B 12 Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol
(6 mL) and water (2 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 220C and seeded with 10 mg of pure rebaudioside A (> 98 %). The mixture was kept at room temperature for 16 hours. The white crystalline product was filtered, washed twice with ethanol:methanol (5.0 mL, 8:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 98 % by HPLC).
EXAMPLE B 13
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol (6 mL) and water (2 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 220C and seeded with 10 mg of pure rebaudioside A (> 98 %),
The mixture was kept at room temperature for 16 hours while stirring. The white crystalline product was filtered, washed twice with ethanol:methanol (5.0 mL, 8:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.4 g of purified product (> 96 % by HPLC).
EXAMPLE B 14
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 15 mL), methanol (5 mL) and water (2.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours while stirring. The white crystalline product was filtered, washed twice with ethanol: methanol (5.0 mL, 3:1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 97 % by HPLC).
EXAMPLE B 15
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 15 mL), methanol (5 mL) and water (3.0 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours while stirring. The white crystalline product was filtered, washed twice with ethanol :methanol (5.0 mL, 3: 1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 2.7 g of purified product (> 97 % by HPLC). EXAMPLE Bl 6
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 15 mL), methanol (5 mL) and water (3.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours while stirring. The white crystalline product was filtered, washed twice with ethanol: methanol (5.0 mL, 3: 1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 2.6 g of purified product (> 99 % by HPLC).
EXAMPLE B17
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 15 mL), methanol (5 mL) and water (4.0 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 16 hours while stirring. The white crystalline product was filtered, washed twice with ethanol methanol (5.0 mL, 3:1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 2.3 g of purified product (> 99 % by HPLC). EXAMPLE B18
Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol (6 mL) and water (2.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 220C. This mixture was stirred at room temperature for 15- 30 minutes during which time crystals started to appear. The stirring was stopped and the mixture was kept at room temperature for 16 hours. The white crystalline product was filtered, washed twice with ethanol methanol (5.0 mL, 8:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.0 g of purified product (> 97 % by HPLC).
EXAMPLE B 19 Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 16 mL), methanol
(6 mL) and water (2.5 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 2 hours. During this time crystals started to appear. The mixture was stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with ethanol :methanol (5.0 mL, 8:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.2 g of purified product (> 98 % by HPLC). EXAMPLE SET C
Figure imgf000026_0001
EXAMPLE Cl
Crude rebaudioside A (80.37 % purity, 5 g), methanol (99 %, 9.5 mL), isopropanol (9.5 mL) and water (1 mL) were combined and heated to about 40-500C for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with an ethanohmethanol (5.0 mL, 8:3, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.85 g of purified product (> 91.0 % by HPLC).
EXAMPLE C2
Crude rebaudioside A (80.37 % purity, 5 g), methanol (99 %, 9.5 mL), sec- butanol (9.5 mL) and water (1 mL) were combined and heated to about 40-500C for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with a methanol: sec-butanol (10.0 mL, 1:1, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 4.0 g of purified product (> 91.0 % by HPLC). EXAMPLE C3
Crude rebaudioside A (80.37 % purity, 5 g), methanol (99 %, 9.5 mL), 1- propanol (9.5 mL) and water (1 mL) were combined and heated to about 40-500C for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with a methanol: 1-propanol (10.0 mL, 1 : 1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.55 g of purified product (> 91.21 % by HPLC).
EXAMPLE C4 Crude rebaudioside A (80.37 % purity, 5 g), ethanol (95 %, 9.5 mL), 1-propanol
(9.5 mL) and water (1 mL) were combined and heated to about 40-500C for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with an ethanol: 1-propanol (10.0 mL, 1 : 1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 2.5 g of purified product (> 94.0 % by HPLC).
EXAMPLE C5
Crude rebaudioside A (80.37 % purity, 5 g), methanol (99 %, 9.5 mL), 1- butanol (9.5 mL) and water (1 mL) were combined and heated to about 40-500C for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with a methanol: 1-butanol (10.0 mL, 1: 1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 3.7 g of purified product (> 91.5 % by HPLC). EXAMPLE C6
Crude rebaudioside A (8037 % purity, 5 g), ethanol (95 %, 9.5 mL), 2-propanoi
(9.5 mL) and water (1 mL) were combined and heated to about 40-500C for 10 minutes.
The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with an ethanol: 2-propanol (10.0 mL, 1 : 1, v/v) mixture and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 2.4 g of purified product (> 93.5 % by HPLC).
EXAMPLE C7
Crude rebaudioside A (77.4 % purity, 5 g), ethanol (95 %, 9.5 mL), sec-butanot (9.5 mL) and water (1 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for
16 hours. The white crystalline product was filtered, washed twice with an ethanol: sec- butanol (10.0 mL, 1 :1, v/v) mixture and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 2.9 g of purified product (> 93.0 % by HPLC).
EXAMPLE C8
Crude rebaudioside A (77.4 % purity, 5 g), methanol (99 %, 9.5 mL), tert- butano! (9,5 mL) and water (1 mL) were combined and heated to about 40-50°C for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with methanol (99 %, 7.0 mL) and dried in a vacuum oven at 5O0C for 16-24 hours under reduced pressure (20 mm) to yield 3.9 g of purified product (> 83.0 % by HPLC).
EXAMPLE C9
Ccrude rebaudioside A (77.4 % purity, 5 g), ethanol (95 %, 9.5 mL), tert- butanol (9.5 mL) and water (1 mL) were combined and heated to reflux for 10 minutes. The clear solution was cooled to 22°C for 2 hours and then stirred at room temperature for 16 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 7.0 mL) and dried in a vacuum oven at 500C for 16-24 hours under reduced pressure (20 mm) to yield 2.9 g of purified product (> 88.0 % by HPLC).
EXAMPLE SET D Table 6: Summar of Exam les Dl -12
Figure imgf000029_0001
EXAMPLE Dl
Crude rebaudioside A (77.4 % purity, 50 g), methanol (99 %, 180 mL) and water (20 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with methanol (99 %, 25 mL), and dried in a vacuum oven at 6O0C for 16-24 hours under reduced pressure (20 mm) to yield 29.8 g of purified product (96.2 % by HPLC).
EXAMPLE D2
Crude rebaudioside A (80.37 % purity, 50 g), methanol (99 %, 160 mL) and water (40 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 1 week. The white crystalline product was filtered, washed twice with methanol (99 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 31.2 g of purified product (95.5 % by HPLC). EXAMPLE D3
Crude rebaudioside A (80.37 % purity, 50 g), ethanol (95 %, 188 mL) and water (12 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 25 mL), and dried in a vacuum oven at 6O0C for 16-24 hours under reduced pressure (20 mm) to yield 37.3 g of purified product (93.4 % by HPLC).
EXAMPLE D4
Crude rebaudioside A (80.37 % purity, 50 g), ethanol (95 %, 184 mL) and water (16 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 31.7 g of purified product (95.3 % by HPLC). EXAMPLE D5
Crude rebaudioside A (80.37 % purity, 50 g), ethanol (95 %, 180 mL) and water (20 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 35.7 g of purified product (94.7 % by HPLC).
EXAMPLE O6
Crude rebaudioside A (80.37 % purity, 50 g), ethanol (95 %, 176 mL) and water (24 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 38.2 g of purified product (97.3 % by HPLC). EXAMPLE D7
Crude rebaudioside A (80.37 % purity, 50 g), ethanol (95 %, 172 niL) and water (28 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 32.0 g of purified product (98.1 % by HPLC).
EXAMPLE D8
Crude rebaudioside A (80.37 % purity, 50 g), ethanol (95 %, 160 mL) and water (40 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with ethanol (95 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 19.8 g of purified product (99.5 % by HPLC). EXAMPLE D9
Crude rebaudioside A (80.37 % purity, 50 g), 1-propanol (180 mL) and water (20 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with 1-propanol (25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 27.0 g of purified product (92.9 % by HPLC).
EXAMPLE DlO
Crude rebaudioside A (80.37 % purity, 50 g), 2-propanol (180 mL) and water (20 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with 2-propanol (25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 34.9 g of purified product (91.4 % by HPLC). EXAMPLE DI l
Crude rebaudioside A (80.37 % purity, 50 g), 1-butanol (180 mL) and water (20 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with 1-butanol (25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 40.6 g of purified product (93.1 % by HPLC).
EXAMPLE D12
Crude rebaudioside A (80.37 % purity, 50 g), 2-butanol (180 mL) and water (20 mL) were combined and heated to reflux for 30 minutes. The mixture was then allowed to cool to ambient temperature for 16-24 hours. The white crystalline product was filtered, washed twice with 2-butanol (25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 40.4 g of purified product (90.5 % by HPLC).
EXAMPLE SET E Table 7: Summary of Examples E1-E3
Figure imgf000032_0001
EXAMPLE El
Crude rebaudioside A (41 % purity, 50 g), ethanol (95 %, 160 mL), methanol (99.8 %, 60 mL) and water (25 mL) were combined by stirring at 22°C. A white product crystallized out in 5-20 hours. The mixture was stirred for additional 48 hours. The white crystalline product was filtered and washed twice with ethanol (95 %, 25 mL). The wet cake of white crystalline product then was slurried in methanol (99.8 %, 200 mL) for 16 hours, filtered, washed twice with methanol (99.8 %, 25 mL), and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 12.7 g of purified product (> 97 % by HPLC). EXAMPLE E2
Crude rebaudioside A (48 % purity, 50 g), ethanol (95 %, 160 mL), methanol (99.8 %, 60 mL) and water (25 niL) was combined by stirring at 22°C. The white product crystallized out in 3-6 hours. The mixture was stirred for additional 48 hours. The white crystalline product was filtered and washed twice with ethanol (95 %, 25 mL). The wet cake of white crystalline product then was slurried in methanol (99.8 %, 300 mL) for 16 hours, filtered, washed twice with methanol (99.8 %, 25 mL) and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 18.6 g of purified product (> 97 % by HPLC). EXAMPLE E3
Crude rebaudioside A (55 % purity, 50 g), ethanol (95 %, 160 mL), methanol (99.8 %, 60 mL) and water (25 mL) was combined by stirring at 22°C. The white product crystallized out in 15-30 minutes. The mixture was stirred for an additional 48 hours. The white crystalline product was filtered and washed twice with ethanol (95 %, 25 mL). The wet cake of white crystalline product was slurried in methanol (99.8 %, 350 mL) for 16 hours, filtered, washed twice with methanol (99.8 %, 25 mL) and dried in a vacuum oven at 600C for 16-24 hours under reduced pressure (20 mm) to yield 22.2 g of purified product (> 97 % by HPLC).
EXAMPLE F A solution of substantially pure rebaudioside A obtained using the purification technique described hereinabove ( >97 % pure by HPLC ) was prepared in double distilled water (12.5 gm in 50 mL, 25 % concentration) by stirring the mixture at 400C for 5 minutes. An amorphous form of rebaudioside A was formed by immediately using the clear solution for spray drying with the Lab-Plant spray drier SD-04 instrument (Lab-Plant Ltd., West Yorkshire, U.K.). The solution was fed through the feed pump into the nozzle atomizer, which atomized the rebaudioside A solution into a spray of droplets with the help of a constant flow of nitrogen / air. Moisture was evaporated from the droplets under controlled temperature conditions (about 90 to about 97°C) and airflow conditions in the drying chamber and resulted in the formation of dry particles. This dry powder (11-12 g, H2O 6.74 %) was discharged continuously from the drying chamber and was collected in a bottle. The rate of dissolution in water at room temperature was determined to be > 35.0 %.
While the invention has been described in detail with respect to specific embodiments thereof, it will be appreciated that those skilled in the art, upon attaining an understanding of the foregoing, may readily conceive of alterations to, variations of, and equivalents to these embodiments. Accordingly, the scope of the present invention should be assessed as that of the appended claims and any equivalents thereof.

Claims

We claim:
1. A method for purifying rebaudioside A comprising the steps of: combining crude rebaudioside A and an aqueous organic solvent to form a rebaudioside A solution, the aqueous organic solution comprising water in an amount from about 10 % to about 25 % by weight; and crystallizing from the rebaudioside A solution in a single step a substantially pure rebaudioside A composition comprising rebaudioside A in a purity greater than about 95 % by weight on a dry basis.
2. The method of claim 1, further comprising the step of heating the rebaudioside A solution.
3. The method of claim 2, further comprising the step of cooling the rebaudioside A solution.
4. The method of claim 1, wherein rebaudioside A solution in the single crystallization step is stirred or unstirred.
5. The method of claim 1 , further comprising the step of seeding (optional) the rebaudioside A solution at an appropriate temperature with an amount of rebaudioside A sufficient to promote crystallization of rebaudioside A.
6. The method of claim 1, further comprising the steps of separating and washing the substantially pure rebaudioside A composition.
7. The method of claim 6, further comprising the step of drying the substantially pure rebaudioside A composition.
8. The method of claim 1 , wherein the crude rebaudioside A comprises substantially no rebaudioside D impurity, and the method further comprises slurrying the substantially pure rebaudioside A composition in an aqueous organic solvent or in an organic solvent.
9. The method of claim 8, further comprising the steps of separating and washing the substantially pure rebaudioside A composition.
10. The method of claim 9, further comprising the step of drying the composition of a substantially pure rebaudioside A.
11. The method of claim 1 , wherein the aqueous organic solvent comprises a mixture of at least one organic solvent and water.
12. The method of claim 11, wherein at least one organic solvent comprises an alcohol.
13. The method of claim 12, wherein the alcohol comprises ethanol.
14. The method of claim 12, wherein the alcohol comprises methanol.
15. The method of claim 12, wherein the alcohol comprises a mixture of ethanol and methanol.
16. The method of claim 15, wherein the ethanol and methanol are present in the aqueous organic solution in a weight ratio from about 20 parts to about 1 parts ethanol to about 1 part methanol.
17. The method of claim 15, wherein the ethanol and methanol are present in the aqueous organic solution in a weight ratio from about 3 parts to about 1 part ethanol to about 1 part methanol.
18. The method of claim 1, wherein the at least one aqueous organic solvent comprises an organic solvent selected from the group consisting of acetone, acetonitrile, methanol, ethanol, 1-propanol, isopropanol, 1-butanol, 2-butanol, tert-butanol, and mixtures thereof.
19. The method of claim 1, wherein the aqueous organic solvent and the crude rebaudioside A are present in the rebaudioside A solution in a weight ratio from about 4 to about 10 parts aqueous organic solvent to about 1 part crude rebaudioside A.
20. The method of claim 1, wherein the aqueous organic solvent and the crude rebaudioside A are present in the rebaudioside A solution in a weight ratio from about 3 to about 5 parts aqueous organic solvent to about 1 part crude rebaudioside A.
21. The method of claim 1 , wherein aqueous organic solvent comprises water in an amount from about 10 % to about 25 % by weight.
22. The method of claim 1, wherein the crude rebaudioside A mixture comprises rebaudioside A in a purity from about 40 % to about 95 % by weight.
23. The method of claim 1, wherein the crude rebaudioside A mixture comprises rebaudioside A in a purity from about 60 % to about 85 % by weight.
24. The method of claim 1, wherein the crude rebaudioside A mixture comprises rebaudioside A in a purity from about 70 % to about 85 % by weight.
25. The method of claim 1, wherein the method is carried out at approximately room temperature.
26. The method of claim 2, wherein the step of heating the rebaudioside A solution comprises heating the rebaudioside A solution to a temperature in a range from about 200C to about 4O0C.
27. The method of claim 2, wherein the step of heating the rebaudioside A solution comprises heating the rebaudioside A solution to a temperature in a range from about 4O0C to about 6O0C.
28. The method of claim 2, wherein the step of heating the rebaudioside A solution comprises heating the rebaudioside A solution to about a reflux temperature.
29. The method of claim 3, wherein the step of cooling the rebaudioside A solution comprises cooling the rebaudioside A solution to a temperature in a range from about 4°C to about 250C.
30. The method of claim 3, wherein the step of cooling the rebaudioside A solution comprises cooling the rebaudioside A solution for about 0.5 hours to about 24 hours.
31. The method of claim I5 wherein the substantially pure rebaudioside A product comprises rebaudioside A in a purity greater than about 97 % rebaudioside A by weight on a dry basis.
32. The method of claim I5 wherein the substantially pure rebaudioside A product comprises rebaudioside A in a purity greater than about 98 % rebaudioside A by weight on a dry basis.
33. The method of claim 1, wherein the substantially pure rebaudioside A product comprises rebaudioside A in a purity greater than about 99 % rebaudioside A by weight on a dry basis.
34. The method of claim 1, further comprising the steps of: heating the rebaudioside A aqueous organic solvent mixture; cooling the rebaudioside A solution; separating and washing a substantially pure rebaudioside A composition; and drying the substantially pure rebaudioside A composition.
35. A substantially pure rebaudioside A composition made according to the method of claim 1, wherein the substantially pure rebaudioside A composition comprises a polymorph having an X-ray diffraction pattern substantially similar to Figure 7.
36. A substantially pure rebaudioside A composition made according to the method of claim 1. wherein the substantially pure rebaudioside A composition comprises a polymorph having an X-ray diffraction pattern substantially similar to Figure 8.
37. A substantially pure rebaudioside A composition made according to the method of claim 1, wherein the substantially pure rebaudioside A composition comprises a polymorph having an X-ray diffraction pattern substantially similar to Figure 9.
38. A substantially pure rebaudioside A composition made according to the method of claim 1, wherein the substantially pure rebaudioside A composition comprises a polymorph having an X-ray diffraction pattern substantially similar to Figure 10.
39. A substantially pure rebaudioside A composition made according to the method of claim 1 , wherein the substantially pure rebaudioside A composition comprises an amorphous form having an X-ray diffraction pattern substantially similar to Figure 11.
40. The method of claim 1, further comprising the step of forming an amorphous form of the substantially pure rebaudioside A composition.
41. The method of claim 38, wherein the step of forming an amorphous form of the substantially pure rebaudioside A composition comprises a method selected from the group consisting of ball milling, precipitation, lyophilization, cryogrinding, and spray- drying.
42. A substantially pure rebaudioside A composition made according to the method of claim 1.
PCT/US2007/069548 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside a WO2007149672A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
AP2008004716A AP2008004716A0 (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside A
JP2009516618A JP5536449B2 (en) 2006-06-19 2007-05-23 Rebaudioside A composition and method for purifying rebaudioside A
CA2655440A CA2655440C (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside a
MX2008016334A MX2008016334A (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside a.
EP07797688.4A EP2037761B1 (en) 2006-06-19 2007-05-23 Method for purifying rebaudioside a
KR1020097000860A KR101494374B1 (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside a
AU2007261243A AU2007261243B2 (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside A
CN2007800226896A CN101472487B (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside a

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80521606P 2006-06-19 2006-06-19
US60/805,216 2006-06-19
US88931807P 2007-02-12 2007-02-12
US60/889,318 2007-02-12

Publications (2)

Publication Number Publication Date
WO2007149672A2 true WO2007149672A2 (en) 2007-12-27
WO2007149672A3 WO2007149672A3 (en) 2008-04-10

Family

ID=38834209

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/069548 WO2007149672A2 (en) 2006-06-19 2007-05-23 Rebaudioside a composition and method for purifying rebaudioside a

Country Status (16)

Country Link
US (1) US8791253B2 (en)
EP (1) EP2037761B1 (en)
JP (1) JP5536449B2 (en)
KR (1) KR101494374B1 (en)
AP (1) AP2008004716A0 (en)
AR (1) AR061516A1 (en)
AU (1) AU2007261243B2 (en)
BR (1) BRPI0713127A2 (en)
CA (1) CA2655440C (en)
CL (1) CL2007001753A1 (en)
MX (1) MX2008016334A (en)
NZ (1) NZ597210A (en)
RU (1) RU2438353C2 (en)
TW (1) TWI419651B (en)
UY (1) UY30388A1 (en)
WO (1) WO2007149672A2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008147725A1 (en) * 2007-05-21 2008-12-04 The Coca-Cola Company Stevioside polymorphic and amorphous forms, methods for their formulation, and uses
WO2011082288A1 (en) * 2009-12-31 2011-07-07 The Coca-Cola Company Rebaudioside a composition and method for purifying rebaudioside a
CN102711521A (en) * 2009-11-06 2012-10-03 伊比西(北京)植物药物技术有限公司 Rebaudioside A polymorphs and methods to prepare them
EP2651960A2 (en) * 2010-12-13 2013-10-23 Purecircle USA Highly soluble rebaudioside d
US8791253B2 (en) 2006-06-19 2014-07-29 The Coca-Cola Company Rebaudioside A composition and method for purifying rebaudioside A
CN104203006A (en) * 2012-03-26 2014-12-10 百事可乐公司 Method for enhancing rebaudioside d solubility in water
US9024012B2 (en) 2010-01-28 2015-05-05 Cargill, Incorporated Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form
WO2018029274A1 (en) 2016-08-09 2018-02-15 Dsm Ip Assets B.V. Crystallization of steviol glycosides
WO2018029272A1 (en) 2016-08-09 2018-02-15 Dsm Ip Assets B.V. Crystallization of steviol glycosides
EP2934181B1 (en) 2012-12-19 2019-09-25 The Coca-Cola Company Compositions and methods for improving rebaudioside x solubility
US11291232B2 (en) 2010-12-13 2022-04-05 Purecircle Sdn Bhd Highly soluble Rebaudioside D
US11414448B2 (en) 2010-11-19 2022-08-16 Cargill, Incorporated Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin
WO2022187819A1 (en) 2021-03-01 2022-09-09 Cargill, Incorporated Xylosylated steviol glycosides and enzymatic methods for production
US11701400B2 (en) 2017-10-06 2023-07-18 Cargill, Incorporated Steviol glycoside compositions with reduced surface tension
US11918014B2 (en) 2019-04-06 2024-03-05 Cargill, Incorporated Sensory modifiers

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943185B1 (en) 2007-03-16 2011-05-17 Pom Wonderful, Llc Method and composition for producing a stable and deodorized form of pomegranate seed oil
US8318459B2 (en) 2011-02-17 2012-11-27 Purecircle Usa Glucosyl stevia composition
US9392799B2 (en) 2011-02-17 2016-07-19 Purecircle Sdn Bhd Glucosyl stevia composition
US8337927B2 (en) * 2005-10-11 2012-12-25 Purecircle Sdn Bhd Process for manufacturing a sweetener and use thereof
US8334006B2 (en) * 2005-10-11 2012-12-18 Purecircle Sdn Bhd Process for manufacturing a sweetener and use thereof
US9107436B2 (en) 2011-02-17 2015-08-18 Purecircle Sdn Bhd Glucosylated steviol glycoside as a flavor modifier
US8257948B1 (en) 2011-02-17 2012-09-04 Purecircle Usa Method of preparing alpha-glucosyl Stevia composition
US8790730B2 (en) 2005-10-11 2014-07-29 Purecircle Usa Process for manufacturing a sweetener and use thereof
US9386797B2 (en) 2011-02-17 2016-07-12 Purecircle Sdn Bhd Glucosyl stevia composition
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
CN101200480B (en) * 2006-12-15 2011-03-30 成都华高药业有限公司 Rebaudioside A extraction method
KR101527237B1 (en) * 2007-01-22 2015-06-08 카아길, 인코포레이팃드 Method of producing purified rebaudioside a compositions using solvent/antisolvent crystallization
US8889199B1 (en) 2007-02-07 2014-11-18 Pom Wonderful Llc Method and composition for producing a stable and deodorized form of pomegranate seed oil
US9877500B2 (en) 2007-03-14 2018-01-30 Concentrate Manufacturing Company Of Ireland Natural beverage products
US8029846B2 (en) 2007-03-14 2011-10-04 The Concentrate Manufacturing Company Of Ireland Beverage products
US8277861B2 (en) * 2007-03-14 2012-10-02 Concentrate Manufacturing Company Of Ireland Beverage products having steviol glycosides and at least one acid
US8277862B2 (en) 2007-03-14 2012-10-02 Concentrate Manufacturing Company Of Ireland Beverage products having steviol glycosides and at least one acid
US20080226788A1 (en) * 2007-03-14 2008-09-18 Concentrate Manufacturing Company Of Ireland Lhg compositions for reducing lingering bitter taste of steviol glycosides
EP2166879B1 (en) * 2007-06-29 2014-10-15 McNeil Nutritionals, LLC Stevia-containing tabletop sweeteners and methods of producing same
WO2009086049A2 (en) * 2007-12-27 2009-07-09 Mc Neil Nutritionals, Llc Synergistic sweetening compositions
US20120058236A1 (en) * 2009-04-09 2012-03-08 Cargill Incorporated Sweetener composition comprising high solubility form of rebaudioside a and method of making
PL2826386T3 (en) 2009-06-16 2023-03-13 Sweet Green Fields International Co., Limited Stevia composition comprising rebaudioside A and D
US8414949B2 (en) * 2009-10-15 2013-04-09 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie yogurt containing the same
US8916138B2 (en) * 2009-10-15 2014-12-23 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie tooth paste composition containing the same
US8414950B2 (en) 2009-10-15 2013-04-09 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie table top tablet containing the same
US8574656B2 (en) * 2009-10-15 2013-11-05 Purecircle Sdn Bhd High-purity Rebaudioside D and low-calorie fruit juice containing the same
WO2011046423A1 (en) 2009-10-15 2011-04-21 Purecircle Sdn Bhd High-purity rebaudioside d and applications
US8414951B2 (en) 2009-10-15 2013-04-09 Purecircle Sdn Bhd High-purity Rebaudioside D and low-calorie soy sauce containing the same
US8420147B2 (en) 2009-10-15 2013-04-16 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie cake containing the same
US8568818B2 (en) * 2009-10-15 2013-10-29 Pure Circle Sdn Bhd High-purity Rebaudioside D and low-calorie carbonated drink containing the same
US8512790B2 (en) 2009-10-15 2013-08-20 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie chocolate containing the same
US8507022B2 (en) * 2009-10-15 2013-08-13 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie carbonated lemon-flavored beverage containing the same
US8414948B2 (en) * 2009-10-15 2013-04-09 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie ice cream containing the same
US8420146B2 (en) * 2009-10-15 2013-04-16 Purecircle Sdn Bhd High-purity Rebaudioside D and low-calorie bread containing the same
US8414952B2 (en) * 2009-10-15 2013-04-09 Purecircle Sdn Bhd High-purity rebaudioside D and low-calorie diet cookies containing the same
US8299224B2 (en) * 2009-10-15 2012-10-30 Purecircle Sdn Bhd High-purity Rebaudioside D
US8703224B2 (en) * 2009-11-04 2014-04-22 Pepsico, Inc. Method to improve water solubility of Rebaudioside D
EP3461342A1 (en) 2009-11-12 2019-04-03 PureCircle USA Inc. Granulation of a stevia sweetener
US20110189360A1 (en) * 2010-02-04 2011-08-04 Pepsico, Inc. Method to Increase Solubility Limit of Rebaudioside D in an Aqueous Solution
CN103079411A (en) 2010-02-08 2013-05-01 可口可乐公司 Solubility enhanced terpene glycoside(s)
EP4108668A1 (en) 2010-03-12 2022-12-28 PureCircle USA Inc. High-purity steviol glycosides
US10696706B2 (en) 2010-03-12 2020-06-30 Purecircle Usa Inc. Methods of preparing steviol glycosides and uses of the same
PT2547220T (en) 2010-03-16 2018-05-09 Imp Sugar Company Process for the manufacture of cocrystallized sucrose - natural sweeteners
US9578895B2 (en) 2010-08-23 2017-02-28 Epc (Beijing) Natural Products Co., Ltd. Rebaudioside A and stevioside compositions
US9510611B2 (en) 2010-12-13 2016-12-06 Purecircle Sdn Bhd Stevia composition to improve sweetness and flavor profile
US9090647B2 (en) * 2010-12-13 2015-07-28 Cargill, Incorporated Crystalline forms of rebaudioside B
WO2012108894A1 (en) 2011-02-10 2012-08-16 Purecircle Usa Stevia composition
US9474296B2 (en) 2011-02-17 2016-10-25 Purecircle Sdn Bhd Glucosyl stevia composition
US11690391B2 (en) 2011-02-17 2023-07-04 Purecircle Sdn Bhd Glucosylated steviol glycoside as a flavor modifier
US9603373B2 (en) 2011-02-17 2017-03-28 Purecircle Sdn Bhd Glucosyl stevia composition
US9795156B2 (en) 2011-03-17 2017-10-24 E.P.C (Beijing) Plant Pharmaceutical Technology Co., Ltd Rebaudioside B and derivatives
US9894922B2 (en) 2011-05-18 2018-02-20 Purecircle Sdn Bhd Glucosyl rebaudioside C
BR112013030701B1 (en) 2011-05-31 2021-07-20 Purecircle Usa Inc PROCESS FOR PRODUCING A STEVIA COMPOSITION COMPRISING REBAUDIOSIDE B WHICH MAY BE USED AS A SWEETENER BOOST, A FLAVOR BOOST AND/OR A SWEETENER
MX341095B (en) 2011-06-03 2016-08-08 Purecircle Usa Stevia composition.
MX364306B (en) 2011-06-20 2019-04-22 Purecircle Usa Inc Stevia composition.
AR087157A1 (en) 2011-06-20 2014-02-26 Gen Biscuit HEALTHY COCKTAIL
US9771434B2 (en) 2011-06-23 2017-09-26 Purecircle Sdn Bhd Products from stevia rebaudiana
US10480019B2 (en) 2011-08-10 2019-11-19 Purecircle Sdn Bhd Process for producing high-purity rubusoside
US20140171520A1 (en) 2011-09-07 2014-06-19 Avetik Markosyan Highly soluble stevia sweetener
FR2979820B1 (en) 2011-09-09 2014-01-10 Lvmh Rech COSMETIC COMPOSITION COMPRISING A BITTER COMPOUND, A FRAGRANCE, A SWEETENER AND A GUSTATIVE AGENT
FR2979819B1 (en) * 2011-09-09 2014-02-28 Lvmh Rech NOVEL COSMETIC COMPOSITION COMPRISING A HYDROPHILIC ORGANIC UV FILTER
US10292412B2 (en) * 2012-02-15 2019-05-21 Kraft Foods Global Brands Llc High solubility natural sweetener compositions
BR112014028819A2 (en) 2012-05-22 2017-07-25 Purecircle Sdn Bhd high purity steviol glycosides
US9752174B2 (en) 2013-05-28 2017-09-05 Purecircle Sdn Bhd High-purity steviol glycosides
US11013248B2 (en) 2012-05-25 2021-05-25 Kraft Foods Group Brands Llc Shelf stable, concentrated, liquid flavorings and methods of preparing beverages with the concentrated liquid flavorings
US20140171519A1 (en) 2012-12-19 2014-06-19 Indra Prakash Compositions and methods for improving rebaudioside x solubility
CN104098739B (en) * 2013-04-09 2016-05-18 江南大学 The preparation method of rebaudioside A molecularly imprinted polymer
DK3003058T4 (en) 2013-06-07 2023-07-24 Purecircle Usa Inc STEVIA EXTRACT CONTAINING SELECTED STEVIOL GLYCOSIDES AS AROMA, SALT AND SWEETNESS PROFILE MODIFIER
US10952458B2 (en) 2013-06-07 2021-03-23 Purecircle Usa Inc Stevia extract containing selected steviol glycosides as flavor, salty and sweetness profile modifier
US10264811B2 (en) * 2014-05-19 2019-04-23 Epc Natural Products Co., Ltd. Stevia sweetener with improved solubility
US10357052B2 (en) 2014-06-16 2019-07-23 Sweet Green Fields USA LLC Rebaudioside A and stevioside with improved solubilities
US10485256B2 (en) 2014-06-20 2019-11-26 Sweet Green Fields International Co., Limited Stevia sweetener with improved solubility with a cyclodextrin
EP3183349B1 (en) 2014-08-19 2020-03-25 Purecircle SDN BHD Method for preparing rebaudioside i
BR112017004240B1 (en) 2014-09-02 2022-04-05 The Coca-Cola Company Process for preparing a composition of untreated aqueous steviol glycoside, untreated aqueous stevia extract prepared by said process and food or beverage
WO2016086233A1 (en) 2014-11-29 2016-06-02 The Coca-Cola Company Novel diterpene glycosides, compositions and purification methods
EP3268487A1 (en) 2015-03-10 2018-01-17 Rijksuniversiteit Groningen Methods for the enzymatic modification of steviol glycosides, modified steviol glycosides obtainable thereby, and the use thereof as sweeteners
EP4275516A3 (en) 2015-10-26 2024-01-24 PureCircle USA Inc. Steviol glycoside compositions
CN108712864A (en) 2015-12-15 2018-10-26 谱赛科美国股份有限公司 steviol glycoside composition
MX2018011075A (en) * 2016-03-14 2019-07-04 Purecircle Usa Inc Highly soluble steviol glycosides.
CN109640693A (en) * 2016-06-14 2019-04-16 谱赛科美国股份有限公司 Steviol glycoside composition, production method and purposes
JP7365707B2 (en) 2018-03-12 2023-10-20 コナゲン インコーポレイテッド Production of steviol glycosides rebaudioside J and rebaudioside N by biosynthesis
CN113046404A (en) * 2020-09-22 2021-06-29 天津大学 Method for producing rebaudioside D by two-step temperature control one-pot method

Family Cites Families (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3723410A (en) * 1970-12-01 1973-03-27 Amazon Natural Drug Co Method of producing stevioside
JPS51142570A (en) * 1975-06-04 1976-12-08 Morita Kagaku Kogyo Method of imparting sweetness to food or pharmaceutical agent
JPS5262300A (en) 1975-11-13 1977-05-23 Ajinomoto Co Inc Isolation of bibaudioside-a by crystallization
US4206222A (en) * 1977-06-23 1980-06-03 Societe Civile Particuliere De Brevets Suffren Method for preparing a substance having properties against collagen diseases and products obtained
US4188390A (en) * 1977-11-05 1980-02-12 Pfizer Inc. Antihypertensive 4-amino-2-[4-(1,4-benzodioxan-2-carbonyl) piperazin-1-yl or homopiperazin-1-yl]quinazolines
US4219571A (en) * 1978-06-15 1980-08-26 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for producing a sweetener
JPS56121455A (en) 1980-02-27 1981-09-24 Ajinomoto Co Inc Separation of stevioside and rebaudioside a by crystallization
JPS56121453A (en) 1980-02-27 1981-09-24 Ajinomoto Co Inc Separation of stevioside and rebaudioside a
FR2488800A1 (en) * 1980-08-19 1982-02-26 Terumo Corp SPRAY EXTRACTS FROM MARGOUSIER WITH ANTINEOPLASTIC ACTIVITY
US4454290A (en) * 1980-09-22 1984-06-12 Dynapol Stevioside analogs
US4381402A (en) * 1980-09-22 1983-04-26 Dynapol Steviol compounds
US4332830A (en) * 1980-09-22 1982-06-01 Dynapol Sweetening with stevioside analogs
JPS5846310B2 (en) 1980-11-19 1983-10-15 丸善化成株式会社 How to isolate the main sweetening components in Stevia
US4361697A (en) * 1981-05-21 1982-11-30 F. K. Suzuki International, Inc. Extraction, separation and recovery of diterpene glycosides from Stevia rebaudiana plants
US4353889A (en) * 1981-06-11 1982-10-12 Dynapol Rebaudioside analogs
US4404367A (en) * 1981-08-26 1983-09-13 Dynapol Glucosubstituented diterpenoid sweeteners
US4402990A (en) * 1981-08-26 1983-09-06 Dynapol Steviolmonoside analogs
JPS58149697A (en) * 1982-02-27 1983-09-06 Dainippon Ink & Chem Inc Preparation of beta-1,3-glycosyl stevioside
JPS5971662A (en) 1982-06-10 1984-04-23 Ikeda Touka Kogyo Kk Sweetener and its preparation
JPS59120073A (en) 1982-12-28 1984-07-11 Ikeda Touka Kogyo Kk Sweetener and its preparation
JPS6027360A (en) 1983-07-25 1985-02-12 Kiyo Kondo Method for improving taste of sweetener
JPS6037950A (en) 1983-08-12 1985-02-27 Sanyo Kokusaku Pulp Co Ltd Method for improving taste of stevia sweetener
US4599403A (en) * 1985-10-07 1986-07-08 Harold Levy Method for recovery of stevioside
JPH0679547B2 (en) 1985-10-16 1994-10-12 大日本インキ化学工業株式会社 Stevia sweetener and method for producing the same
DE3810681A1 (en) * 1988-03-29 1989-10-12 Udo Kienle METHOD FOR PRODUCING A NATURAL SWEETENER BASED ON STEVIA REBAUDIANA AND ITS USE
JPH06192283A (en) * 1992-12-17 1994-07-12 Ikeda Pan:Kk Method for production pure rebaudioside a
US5530106A (en) * 1993-03-12 1996-06-25 Mcneil-Ppc, Inc. Recovery of sucralose intermediates
USPP10563P (en) 1996-05-29 1998-08-18 Royal-Sweet International Technologies Ltd. Part. Stevia plant named `RSIT 95-166-13`
USPP10562P (en) 1996-05-29 1998-08-18 Royal-Sweet International Technologies Ltd. Part. Stevia plant named `RSIT 94-1306`
USPP10564P (en) 1996-05-29 1998-08-18 Royal-Sweet International Technologies Ltd. Stevia plant named `RSIT 94-751`
US5962678A (en) * 1996-09-13 1999-10-05 Alberta Research Council Method of extracting selected sweet glycosides from the Stevia rebaudiana plant
US5972120A (en) * 1997-07-19 1999-10-26 National Research Council Of Canada Extraction of sweet compounds from Stevia rebaudiana Bertoni
US6255557B1 (en) * 1998-03-31 2001-07-03 Her Majesty The Queen In Right Of Canada As Represented By The Ministerof Agriculture And Agri-Food Canada Stevia rebaudiana with altered steviol glycoside composition
BE1012249A3 (en) * 1998-10-27 2000-08-01 Brouwers Louis Jean Hilda Sweet maker.
AU1628700A (en) * 1998-11-20 2000-06-13 Nutrasweet Company, The Amorphous N-(N-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methyl ester
WO2000032621A1 (en) 1998-11-25 2000-06-08 The Nutrasweet Company PROCESS FOR PURIFICATION OF N- [N-(3,3-DIMETHYLBUTYL) -L-α-ASPARTYL] -L-PHENYLALANINE 1-METHYL ESTER
AU1832500A (en) * 1998-11-25 2000-06-19 Nutrasweet Company, The Purification of N-(N-(3,3-dimethylbutyl)-l-alpha-aspartyl)-l-phenylalanine 1-methyl ester via crystallization
WO2000052019A2 (en) 1999-03-03 2000-09-08 The Nutrasweet Company Crystallization products of neotame and methods for producing same
CA2278083A1 (en) 1999-07-20 2001-01-20 James Kenneth Laidler Method of extracting selected sweet glycosides from the stevia rebaudiana plant
AU4459400A (en) * 1999-07-28 2001-02-19 Nutrasweet Company, The A method for the purification of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartyl]-l-phenylalanine 1-methyl ester
US7306815B2 (en) * 2000-08-31 2007-12-11 Phenolics, Llc Compositions enriched in phenolic compounds and methods for producing the same
AU2691802A (en) * 2000-11-17 2002-05-27 Mcneil Ppc Inc Improved sucralose composition and process for its preparation
KR100858768B1 (en) 2001-06-21 2008-09-16 교와 핫꼬 고교 가부시끼가이샤 Process for Producing Plant Extract Containing Plant Powder
KR100851610B1 (en) * 2001-09-21 2008-08-12 디아이씨 가부시끼가이샤 Sweetener and process for producing the same
US6998480B2 (en) * 2002-03-08 2006-02-14 Tate & Lyle Public Limited Company Process for improving sucralose purity and yield
US7049435B2 (en) * 2002-03-08 2006-05-23 Tate & Lyle Public Limited Company Extractive methods for purifying sucralose
US20040030124A1 (en) * 2002-08-06 2004-02-12 Catani Steven J. Process for recovering chlorosucrose compounds
KR100944242B1 (en) 2004-10-04 2010-02-24 카운슬 오브 사이언티픽 앤드 인더스트리얼 리서치 Process for production of steviosides from Stevia Rebaudiana Bertoni
US7923552B2 (en) * 2004-10-18 2011-04-12 SGF Holdings, LLC High yield method of producing pure rebaudioside A
US7838044B2 (en) * 2004-12-21 2010-11-23 Purecircle Sdn Bhd Extraction, separation and modification of sweet glycosides from the Stevia rebaudiana plant
US20060142555A1 (en) * 2004-12-23 2006-06-29 Council Of Scientific And Industrial Research Process for production of steviosides from stevia rebaudiana bertoni
US7862845B2 (en) * 2005-10-11 2011-01-04 Purecircle Sdn Bhd Process for manufacturing a sweetener and use thereof
US7807206B2 (en) * 2005-10-11 2010-10-05 Purecircle Sdn Bhd Sweetner and use
US8956677B2 (en) * 2005-11-23 2015-02-17 The Coca-Cola Company High-potency sweetener composition with glucosamine and compositions sweetened therewith
US20070116831A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Dental Composition with High-Potency Sweetener
US20070134391A1 (en) * 2005-11-23 2007-06-14 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Autoimmune Disorders and Compositions Sweetened Therewith
US20070116829A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Pharmaceutical Composition with High-Potency Sweetener
US20070116839A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition With C-Reactive Protein Reducing Substance and Compositions Sweetened Therewith
US8367137B2 (en) * 2005-11-23 2013-02-05 The Coca-Cola Company High-potency sweetener composition with fatty acid and compositions sweetened therewith
US8435588B2 (en) * 2005-11-23 2013-05-07 The Coca-Cola Company High-potency sweetener composition with an anti-inflammatory agent and compositions sweetened therewith
US8993027B2 (en) * 2005-11-23 2015-03-31 The Coca-Cola Company Natural high-potency tabletop sweetener compositions with improved temporal and/or flavor profile, methods for their formulation, and uses
US20070116836A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition for Treatment and/or Prevention of Osteoporosis and Compositions Sweetened Therewith
US8377491B2 (en) * 2005-11-23 2013-02-19 The Coca-Cola Company High-potency sweetener composition with vitamin and compositions sweetened therewith
US20070116833A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-Potency Sweetener Composition with Calcium and Compositions Sweetened Therewith
US20070116823A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener for hydration and sweetened hydration composition
US8435587B2 (en) * 2005-11-23 2013-05-07 The Coca-Cola Company High-potency sweetener composition with long-chain primary aliphatic saturated alcohol and compositions sweetened therewith
US20070116822A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company High-potency sweetener composition with saponin and compositions sweetened therewith
US8945652B2 (en) * 2005-11-23 2015-02-03 The Coca-Cola Company High-potency sweetener for weight management and compositions sweetened therewith
US9101160B2 (en) * 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070116820A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Edible gel compositions comprising high-potency sweeteners
US8367138B2 (en) * 2005-11-23 2013-02-05 The Coca-Cola Company Dairy composition with high-potency sweetener
AU2006318781B2 (en) * 2005-11-23 2012-11-01 The Coca-Cola Company Natural high-potency sweetener compositions with improved temporal profile and/or flavor profile, methods for their formulation, and uses
US9144251B2 (en) * 2005-11-23 2015-09-29 The Coca-Cola Company High-potency sweetener composition with mineral and compositions sweetened therewith
US8512789B2 (en) * 2005-11-23 2013-08-20 The Coca-Cola Company High-potency sweetener composition with dietary fiber and compositions sweetened therewith
US8962058B2 (en) * 2005-11-23 2015-02-24 The Coca-Cola Company High-potency sweetener composition with antioxidant and compositions sweetened therewith
US20070116800A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Chewing Gum with High-Potency Sweetener
US8524303B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with phytosterol and compositions sweetened therewith
US20070116825A1 (en) * 2005-11-23 2007-05-24 The Coca-Cola Company Confection with High-Potency Sweetener
US8940350B2 (en) * 2005-11-23 2015-01-27 The Coca-Cola Company Cereal compositions comprising high-potency sweeteners
US8524304B2 (en) * 2005-11-23 2013-09-03 The Coca-Cola Company High-potency sweetener composition with probiotics/prebiotics and compositions sweetened therewith
US9012626B2 (en) * 2006-06-19 2015-04-21 The Coca-Cola Company Rebaudioside a composition and method for purifying rebaudioside a
US8791253B2 (en) 2006-06-19 2014-07-29 The Coca-Cola Company Rebaudioside A composition and method for purifying rebaudioside A
US8030481B2 (en) 2007-05-21 2011-10-04 The Coca-Cola Company Stevioside polymorphic and amorphous forms, methods for their formulation, and uses

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8791253B2 (en) 2006-06-19 2014-07-29 The Coca-Cola Company Rebaudioside A composition and method for purifying rebaudioside A
US9012626B2 (en) 2006-06-19 2015-04-21 The Coca-Cola Company Rebaudioside a composition and method for purifying rebaudioside a
JP2010528029A (en) * 2007-05-21 2010-08-19 ザ・コカ−コーラ・カンパニー Polymorphs and amorphous forms of stevioside, methods of blending them, and methods of use
AU2008256959B2 (en) * 2007-05-21 2013-07-11 The Coca-Cola Company Stevioside polymorphic and amorphous forms, methods for their formulation, and uses
WO2008147725A1 (en) * 2007-05-21 2008-12-04 The Coca-Cola Company Stevioside polymorphic and amorphous forms, methods for their formulation, and uses
CN102711521A (en) * 2009-11-06 2012-10-03 伊比西(北京)植物药物技术有限公司 Rebaudioside A polymorphs and methods to prepare them
AU2010339459B2 (en) * 2009-12-31 2016-02-25 The Coca-Cola Company Rebaudioside A composition and method for purifying rebaudioside A
WO2011082288A1 (en) * 2009-12-31 2011-07-07 The Coca-Cola Company Rebaudioside a composition and method for purifying rebaudioside a
CN102770436A (en) * 2009-12-31 2012-11-07 可口可乐公司 Rebaudioside A composition and method for purifying rebaudioside A
CN106167509A (en) * 2009-12-31 2016-11-30 可口可乐公司 Rebaudioside A compositions and the method for purification rebaudioside A
US9024012B2 (en) 2010-01-28 2015-05-05 Cargill, Incorporated Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form
US11414448B2 (en) 2010-11-19 2022-08-16 Cargill, Incorporated Method for the enrichment of rebaudioside b and/or rebaudioside d in stevia-derived glycoside compositions using adsorb-desorb chromatography with a macroporous neutral adsorbent resin
EP2651960A2 (en) * 2010-12-13 2013-10-23 Purecircle USA Highly soluble rebaudioside d
US11291232B2 (en) 2010-12-13 2022-04-05 Purecircle Sdn Bhd Highly soluble Rebaudioside D
US11950611B2 (en) 2010-12-13 2024-04-09 Purecircle Sdn Bhd Highly soluble Rebaudioside D
EP2651960A4 (en) * 2010-12-13 2014-07-09 Purecircle Usa Highly soluble rebaudioside d
CN104203006A (en) * 2012-03-26 2014-12-10 百事可乐公司 Method for enhancing rebaudioside d solubility in water
EP2934181B1 (en) 2012-12-19 2019-09-25 The Coca-Cola Company Compositions and methods for improving rebaudioside x solubility
CN109563117A (en) * 2016-08-09 2019-04-02 帝斯曼知识产权资产管理有限公司 The crystallization of steviol glycoside
WO2018029272A1 (en) 2016-08-09 2018-02-15 Dsm Ip Assets B.V. Crystallization of steviol glycosides
US11878992B2 (en) 2016-08-09 2024-01-23 Dsm Ip Assets B.V. Crystallization of steviol glycosides
WO2018029274A1 (en) 2016-08-09 2018-02-15 Dsm Ip Assets B.V. Crystallization of steviol glycosides
US11701400B2 (en) 2017-10-06 2023-07-18 Cargill, Incorporated Steviol glycoside compositions with reduced surface tension
US11717549B2 (en) 2017-10-06 2023-08-08 Cargill, Incorporated Steviol glycoside solubility enhancers
US12097231B2 (en) 2017-10-06 2024-09-24 Cargill, Incorporated Steviol glycoside compositions with reduced surface tension
US11918014B2 (en) 2019-04-06 2024-03-05 Cargill, Incorporated Sensory modifiers
WO2022187819A1 (en) 2021-03-01 2022-09-09 Cargill, Incorporated Xylosylated steviol glycosides and enzymatic methods for production

Also Published As

Publication number Publication date
TW200814939A (en) 2008-04-01
AR061516A1 (en) 2008-09-03
CA2655440A1 (en) 2007-12-27
AU2007261243A1 (en) 2007-12-27
TWI419651B (en) 2013-12-21
EP2037761B1 (en) 2016-07-06
CL2007001753A1 (en) 2008-05-16
JP2009541334A (en) 2009-11-26
KR20090021386A (en) 2009-03-03
AP2008004716A0 (en) 2008-12-31
RU2008149916A (en) 2010-07-27
CA2655440C (en) 2014-12-09
US20070292582A1 (en) 2007-12-20
WO2007149672A3 (en) 2008-04-10
EP2037761A2 (en) 2009-03-25
US8791253B2 (en) 2014-07-29
NZ597210A (en) 2013-05-31
JP5536449B2 (en) 2014-07-02
BRPI0713127A2 (en) 2012-04-17
MX2008016334A (en) 2009-01-16
AU2007261243B2 (en) 2013-05-09
KR101494374B1 (en) 2015-02-17
UY30388A1 (en) 2008-01-02
RU2438353C2 (en) 2012-01-10

Similar Documents

Publication Publication Date Title
US8791253B2 (en) Rebaudioside A composition and method for purifying rebaudioside A
AU2008256959B2 (en) Stevioside polymorphic and amorphous forms, methods for their formulation, and uses
CA2784810C (en) Rebaudioside a composition and method for purifying rebaudioside a
US8937168B2 (en) Method of producing purified rebaudioside A compositions using solvent/antisolvent crystallization
CA2788359C (en) Methods to treat mixtures of glycosides to obtain one or more of these glycosides in more pure form
CN101472487B (en) Rebaudioside a composition and method for purifying rebaudioside a
WO2022132971A1 (en) Method for purifying a crude composition comprising one or more steviol glycosides

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200780022689.6

Country of ref document: CN

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 573481

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: 12008502739

Country of ref document: PH

WWE Wipo information: entry into national phase

Ref document number: 2007261243

Country of ref document: AU

ENP Entry into the national phase

Ref document number: 2655440

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2009516618

Country of ref document: JP

Ref document number: 10344/DELNP/2008

Country of ref document: IN

WWE Wipo information: entry into national phase

Ref document number: MX/A/2008/016334

Country of ref document: MX

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007261243

Country of ref document: AU

Date of ref document: 20070523

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1020097000860

Country of ref document: KR

REEP Request for entry into the european phase

Ref document number: 2007797688

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09003499

Country of ref document: CO

Ref document number: 2007797688

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2008149916

Country of ref document: RU

Kind code of ref document: A

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07797688

Country of ref document: EP

Kind code of ref document: A2